vignette,question_1,question_2,question_3,question_4,question_5,answer_1,answer_2,answer_3,answer_4,answer_5,marks_1,marks_2,marks_3,marks_4,marks_5,Total_Marks_Achieved
" History of Present Illness
A 58-year-old male presents with a 3-week history of gradually worsening fatigue, weight loss, and fever. Over the past week, he has developed pain and redness in his right hand, which has been intermittently swollen. He denies trauma or any recent infections. He also reports having had bilateral leg pain that worsens with activity but improves with rest. The patient has no history of similar symptoms. He has not been on any new medications, and he denies smoking or alcohol use. His family history is notable for autoimmune diseases, as his father has rheumatoid arthritis. 

  Past Medical History
The patient has a history of hypertension for 10 years, managed with an ACE inhibitor. He has no known history of autoimmune diseases or vasculitis. He underwent a cholecystectomy 5 years ago . 

  Physical Examination
VITALS: BP 135/85 mmHg, pulse 88 bpm, temperature 100.4°F. 
GEN: Ill-appearing, mildly febrile, visibly fatigued. 
CARDIAC: Regular rhythm, no murmurs, Feeble peripheral pulses 
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender, no hepatosplenomegaly. 
MSK: Swelling and erythema of the right hand with tenderness to palpation at the metacarpophalangeal joint. Bilateral calf tenderness with no signs of deep venous thrombosis. 
EXT: No edema, but marked tenderness in the lower extremities. 
SKIN: Petechial rash over the anterior shin. 

  Laboratory Results
WBC: 12 x 103 cells/μL (elevated). Hemoglobin: 11.8 g/dL. ESR: 65 mm/h (elevated). Positive anti-ds DNA antibodies. CRP: 45 mg/L (elevated). Urinalysis: 2+ protein, no blood. Creatinine: 1.2 mg/dL.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Systemic Lupus Erythematosus (SLE)**: The presence of anti-dsDNA antibodies, elevated ESR, and CRP, along with symptoms such as fever, fatigue, weight loss, and petechial rash, suggest a possible diagnosis of SLE. The patient's family history of autoimmune diseases also supports this diagnosis.
2. **Rheumatoid Arthritis (RA)**: The patient's symptoms of swelling, erythema, and tenderness in the metacarpophalangeal joint, as well as bilateral calf tenderness, are consistent with RA. The elevated ESR and CRP also support this diagnosis. The patient's family history of RA (father with RA) further increases the likelihood of this diagnosis.
3. **Vasculitis (e.g., Polyarteritis Nodosa or Giant Cell Arteritis)**: The patient's symptoms of fever, fatigue, weight loss, and petechial rash, along with the presence of feeble peripheral pulses and marked tenderness in the lower extremities, suggest a possible diagnosis of vasculitis. The elevated WBC and CRP also support this diagnosis. However, further testing, such as angiography or biopsy, would be needed to confirm this diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Systemic Lupus Erythematosus (SLE)**

Supporting findings and risk factors:

* Positive anti-dsDNA antibodies: a specific antibody associated with SLE
* Elevated ESR (65 mm/h) and CRP (45 mg/L): indicate inflammation, which is a hallmark of SLE
* Fever, fatigue, and weight loss: common systemic symptoms of SLE
* Petechial rash: a type of skin manifestation that can occur in SLE
* Proteinuria (2+ protein on urinalysis): suggests kidney involvement, which is common in SLE
* Family history of autoimmune diseases (father with rheumatoid arthritis): increases the risk of developing an autoimmune disease like SLE
* Female sex is a risk factor, but SLE can also occur in males, especially those with a family history of autoimmune diseases

**2. Rheumatoid Arthritis (RA)**

Supporting findings and risk factors:

* Swelling, erythema, and tenderness in the metacarpophalangeal joint: suggest inflammatory arthritis, which is a hallmark of RA
* Bilateral calf tenderness: may indicate symmetric polyarthritis, which is common in RA
* Elevated ESR (65 mm/h) and CRP (45 mg/L): indicate inflammation, which is a key feature of RA
* Family history of RA (father with RA): increases the risk of developing RA
* Male sex is less common in RA, but can still occur, especially in those with a family history of the disease
* Age (58 years) is within the common age range for developing RA

**3. Vasculitis (e.g., Polyarteritis Nodosa or Giant Cell Arteritis)**

Supporting findings and risk factors:

* Fever, fatigue, and weight loss: common systemic symptoms of vasculitis
* Petechial rash: a type of skin manifestation that can occur in vasculitis
* Feeble peripheral pulses: suggest vascular involvement, which is a hallmark of vasculitis
* Marked tenderness in the lower extremities: may indicate vascular inflammation or ischemia
* Elevated WBC (12 x 10^3 cells/μL) and CRP (45 mg/L): indicate inflammation, which is a key feature of vasculitis
* Age (58 years) is within the common age range for developing certain types of vasculitis, such as Polyarteritis Nodosa
* Male sex is more common in certain types of vasculitis, such as Polyarteritis Nodosa

Note that these findings and risk factors are not exhaustive, and further testing and evaluation would be needed to confirm or rule out each diagnosis.","Here are the findings that oppose each of the possible diagnoses, or findings that were expected but not present:

**1. Systemic Lupus Erythematosus (SLE)**

Opposing findings:

* The patient's symptoms are relatively acute, with a 3-week history of worsening fatigue, fever, and weight loss. SLE often has a more chronic course.
* The patient does not have a history of photosensitivity, oral ulcers, or alopecia, which are common manifestations of SLE.
* The patient's urinalysis shows only 2+ proteinuria, without hematuria or casts, which is a relatively mild renal involvement compared to what is often seen in SLE.
* The patient's blood pressure is relatively well-controlled (135/85 mmHg), which is not typical of SLE patients who often have hypertension due to renal involvement.

Expected findings that are not present:

* Mucosal ulcers or nasal ulcers, which are common in SLE
* Serositis (pleuritis or pericarditis), which is a common manifestation of SLE
* Neurological symptoms, such as seizures or psychosis, which can occur in SLE

**2. Rheumatoid Arthritis (RA)**

Opposing findings:

* The patient's symptoms are relatively acute, with a 3-week history of worsening fatigue, fever, and weight loss. RA often has a more gradual onset.
* The patient does not have a history of morning stiffness, which is a common symptom of RA.
* The patient's joint involvement is relatively limited, with only one joint (metacarpophalangeal joint) showing signs of inflammation. RA often involves multiple joints in a symmetric pattern.
* The patient's laboratory results do not show rheumatoid factor or anti-CCP antibodies, which are often present in RA.

Expected findings that are not present:

* Symmetric polyarthritis, which is a hallmark of RA
* Morning stiffness lasting more than 1 hour, which is a common symptom of RA
* Subcutaneous nodules, which can occur in RA
* Eye symptoms, such as dryness or inflammation, which can occur in RA

**3. Vasculitis (e.g., Polyarteritis Nodosa or Giant Cell Arteritis)**

Opposing findings:

* The patient's age (58 years) is relatively young for Giant Cell Arteritis, which typically occurs in older adults.
* The patient does not have a history of headache, jaw claudication, or visual symptoms, which are common manifestations of Giant Cell Arteritis.
* The patient's laboratory results do not show anemia or elevated liver enzymes, which can occur in vasculitis.
* The patient's physical examination does not show any signs of organ-specific involvement, such as abdominal pain or neuropathy, which can occur in vasculitis.

Expected findings that are not present:

* Organ-specific involvement, such as renal failure or neuropathy, which can occur in vasculitis
* Skin lesions, such as nodules or ulcers, which can occur in vasculitis
* Eye symptoms, such as visual loss or eye pain, which can occur in vasculitis
* Abdominal pain or gastrointestinal bleeding, which can occur in vasculitis

Note that these opposing findings do not necessarily rule out each diagnosis, but rather suggest that the diagnosis may be less likely or that further evaluation is needed to confirm the diagnosis.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Systemic Lupus Erythematosus (SLE)**

The patient's presentation with a 3-week history of worsening fatigue, fever, weight loss, and joint pain, along with the presence of a petechial rash and proteinuria, is consistent with SLE. The positive anti-dsDNA antibodies and elevated ESR and CRP also support this diagnosis.

While the patient's symptoms and laboratory results could also be consistent with other diagnoses, such as rheumatoid arthritis or vasculitis, the presence of anti-dsDNA antibodies and the patient's overall clinical presentation are more suggestive of SLE.

The patient's family history of autoimmune diseases, including his father's rheumatoid arthritis, also increases the likelihood of SLE.

**Reasons for choosing SLE over other diagnoses:**

* The presence of anti-dsDNA antibodies, which are specific for SLE
* The patient's systemic symptoms, such as fever, fatigue, and weight loss, which are common in SLE
* The presence of a petechial rash, which is a common skin manifestation of SLE
* The patient's proteinuria, which suggests renal involvement, which is common in SLE
* The patient's family history of autoimmune diseases, which increases the risk of developing SLE

**Next steps:**

* Further evaluation to assess the extent of organ involvement, including renal function, cardiovascular risk, and neurological function
* Initiation of treatment with corticosteroids and immunosuppressive agents to control symptoms and prevent organ damage
* Close monitoring of the patient's condition and adjustment of treatment as needed to achieve remission and prevent flares.","Based on the final diagnosis of Systemic Lupus Erythematosus (SLE), the following additional steps should be taken:

**Immediate steps:**

1. **Initiate corticosteroid therapy**: Start the patient on a moderate to high dose of corticosteroids (e.g., prednisone 20-40 mg/day) to control inflammation and prevent organ damage.
2. **Immunosuppressive therapy**: Consider adding an immunosuppressive agent (e.g., hydroxychloroquine, azathioprine, or mycophenolate mofetil) to reduce the risk of flares and prevent organ damage.
3. **Antimalarial therapy**: Consider adding an antimalarial agent (e.g., hydroxychloroquine) to reduce the risk of flares and prevent organ damage.
4. **Pain management**: Manage the patient's pain with acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs) as needed.

**Diagnostic tests:**

1. **Complete blood count (CBC)**: Repeat the CBC to monitor for anemia, leukopenia, or thrombocytopenia.
2. **Blood chemistry tests**: Repeat blood chemistry tests (e.g., creatinine, liver function tests) to monitor for organ damage.
3. **Urinalysis**: Repeat urinalysis to monitor for proteinuria, hematuria, or casts.
4. **Imaging studies**: Consider ordering imaging studies (e.g., chest X-ray, abdominal ultrasound) to evaluate for organ damage or involvement.
5. **Lupus serology**: Repeat lupus serology tests (e.g., anti-dsDNA, anti-Sm) to monitor for disease activity.

**Consultations:**

1. **Rheumatology consultation**: Consult with a rheumatologist to confirm the diagnosis and develop a treatment plan.
2. **Nephrology consultation**: Consult with a nephrologist if the patient has significant proteinuria or renal impairment.
3. **Cardiology consultation**: Consult with a cardiologist if the patient has a history of cardiovascular disease or if cardiovascular risk factors are present.

**Patient education:**

1. **Disease education**: Educate the patient about SLE, its symptoms, and its treatment.
2. **Medication education**: Educate the patient about the medications prescribed, including their potential side effects and interactions.
3. **Lifestyle modifications**: Encourage the patient to make lifestyle modifications (e.g., avoiding sun exposure, staying hydrated) to reduce the risk of flares and prevent organ damage.

**Follow-up:**

1. **Regular follow-up appointments**: Schedule regular follow-up appointments (e.g., every 2-3 months) to monitor the patient's condition and adjust treatment as needed.
2. **Telephone follow-up**: Consider regular telephone follow-up to monitor the patient's condition and provide support between appointments.","{""Score"":3,""Rationale"":""The answer includes Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), and Vasculitis, all of which are listed in the high‑scoring rubric, earning full marks.""}","{""Score"":6,""Rationale"":""Student provided the key findings for SLE (anti‑dsDNA, fatigue, weight loss, fever, elevated ESR/CRP, petechial rash, family history), for Vasculitis (fever, weight loss, rash) and for RA (hand swelling/tenderness, family history). These match the concepts in the high‑scoring example, earning full points. No peripheral vascular disease criteria were needed for the 6‑point total.""}","{""Score"":4,""Rationale"":""The answer includes the required opposing findings for Rheumatoid Arthritis (absence of morning stiffness and joint deformity) and for Vasculitis (no obvious vessel involvement or organ damage), matching the rubric. It does not mention the specific SLE criteria listed (butterfly rash or definitive lack of renal involvement) nor the peripheral vascular disease criterion (palpable peripheral pulses), so no points are awarded for those items.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Systemic Lupus Erythematosus (SLE) and cites the same key clinical findings (fever, weight loss, elevated ESR/CRP, rash, proteinuria) that are listed in the high‑scoring example, thus meeting the rubric criteria for full credit.""}","{""Score"":4,""Rationale"":""The answer includes a rheumatology consultation (matches referral to rheumatologist) and mentions hydroxychloroquine as a treatment (matches starting hydroxychloroquine). It does not mention performing a kidney biopsy for persistent proteinuria, so no points for that item.""}",19.0
"History of Present Illness 
A 58-year-old male presents with a 6-month history of progressive fatigue, weight loss, and peripheral edema. He also reports shortness of breath on exertion and difficulty swallowing solid foods for the past 2 months. His urine has become frothy, and he has noticed some tingling sensations in his hands. He denies chest pain, fever, or night sweats. There is no history of hypertension, diabetes, or known heart disease. 
Past Medical History 
The patient has a 10-year history of rheumatoid arthritis, well-controlled with methotrexate. He denies smoking or alcohol use. Family history is negative for any genetic disorders. 
Physical Examination 
VITALS: BP 110/70 mmHg, pulse 90/min, temperature 98.4°F. 
GEN: Thin, pale, fatigued. 
CARDIAC: No murmurs, but there is a slight periorbital edema. 
PULM: Clear to auscultation bilaterally. 
ABD: Mild hepatomegaly (2 cm below the costal margin), no tenderness. 
EXT: Bilateral pedal edema, no erythema or ulcers. 
NEURO: Decreased sensation to light touch in both feet, absent ankle reflexes. 

Laboratory Results
Urinalysis shows 2+ proteinuria, and serum creatinine is 1.5 mg/dL. The BNP is elevated at 550 pg/mL. Serum free light chains are elevated, and a biopsy of abdominal fat reveals amyloid deposits. Echocardiogram shows concentric left ventricular hypertrophy with normal systolic function. Hemoglobin levels within normal range.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Amyloid Light-Chain (AL) Amyloidosis**: The presence of elevated serum free light chains, proteinuria, and amyloid deposits on abdominal fat biopsy are highly suggestive of AL amyloidosis, a condition where abnormal proteins (light chains) produced by plasma cells accumulate in various organs, leading to tissue damage and dysfunction.
2. **Cardiac Amyloidosis**: The patient's symptoms of shortness of breath on exertion, peripheral edema, and elevated BNP, combined with the echocardiogram findings of concentric left ventricular hypertrophy, suggest cardiac involvement, which is consistent with cardiac amyloidosis.
3. **Systemic Amyloidosis with Rheumatoid Arthritis**: The patient's 10-year history of rheumatoid arthritis, a chronic inflammatory condition, may be related to the development of amyloidosis, as chronic inflammation can increase the risk of amyloid deposition. The presence of amyloid deposits in abdominal fat and elevated serum free light chains supports this diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Amyloid Light-Chain (AL) Amyloidosis**

* **Elevated serum free light chains**: This is a key diagnostic criterion for AL amyloidosis, as it indicates the presence of abnormal light chain proteins in the blood.
* **Amyloid deposits on abdominal fat biopsy**: The presence of amyloid deposits in tissue is a definitive diagnostic feature of amyloidosis.
* **Proteinuria (2+ on urinalysis)**: Kidney involvement is common in AL amyloidosis, and proteinuria is a frequent finding.
* **Weight loss and fatigue**: These are non-specific symptoms that can occur in AL amyloidosis due to the systemic nature of the disease.
* **History of rheumatoid arthritis**: While not a direct risk factor, chronic inflammatory conditions like rheumatoid arthritis can increase the risk of developing AL amyloidosis.

**2. Cardiac Amyloidosis**

* **Elevated BNP (550 pg/mL)**: Elevated BNP is a marker of cardiac stress and is often elevated in cardiac amyloidosis.
* **Concentric left ventricular hypertrophy on echocardiogram**: This is a characteristic finding in cardiac amyloidosis, as the amyloid deposits can cause thickening of the heart muscle.
* **Shortness of breath on exertion**: This symptom is consistent with cardiac involvement, as the heart's ability to pump blood effectively is impaired.
* **Peripheral edema**: Fluid accumulation in the body can occur due to cardiac dysfunction, which is consistent with cardiac amyloidosis.
* **Periorbital edema**: This finding is also consistent with cardiac involvement, as fluid can accumulate in the tissues due to cardiac dysfunction.

**3. Systemic Amyloidosis with Rheumatoid Arthritis**

* **10-year history of rheumatoid arthritis**: Chronic inflammatory conditions like rheumatoid arthritis can increase the risk of developing amyloidosis.
* **Elevated serum free light chains**: This finding is consistent with AL amyloidosis, which can occur in the context of chronic inflammation.
* **Amyloid deposits on abdominal fat biopsy**: This finding confirms the presence of amyloidosis, which can be related to the patient's rheumatoid arthritis.
* **Systemic symptoms (fatigue, weight loss, peripheral edema)**: These symptoms can occur in systemic amyloidosis, which can involve multiple organ systems.
* **Neurological symptoms (tingling sensations in hands, decreased sensation to light touch in feet)**: These symptoms can occur in systemic amyloidosis, which can involve the nervous system.","Here are the findings that oppose or do not support each of the possible diagnoses:

**1. Amyloid Light-Chain (AL) Amyloidosis**

* **Normal hemoglobin levels**: AL amyloidosis can be associated with anemia, which is not present in this patient.
* **No history of multiple myeloma or other plasma cell disorders**: AL amyloidosis is often associated with underlying plasma cell disorders, but this patient has no such history.
* **No lytic bone lesions on physical examination**: AL amyloidosis can be associated with bone lesions, but none were found on physical examination.
* **Normal pulse and blood pressure**: AL amyloidosis can cause autonomic dysfunction, leading to orthostatic hypotension, but this patient's vital signs are normal.
* **Absence of macroglossia**: AL amyloidosis can cause enlargement of the tongue (macroglossia), but this patient does not have this finding.

**2. Cardiac Amyloidosis**

* **Normal systolic function on echocardiogram**: Cardiac amyloidosis often leads to restrictive cardiomyopathy, which can impair systolic function, but this patient's systolic function is normal.
* **No murmurs on cardiac examination**: Cardiac amyloidosis can cause valvular dysfunction, leading to murmurs, but none were found on physical examination.
* **No history of arrhythmias**: Cardiac amyloidosis can cause arrhythmias, but this patient has no such history.
* **Normal pulmonary examination**: Cardiac amyloidosis can cause pulmonary congestion, leading to abnormal lung sounds, but this patient's lungs are clear to auscultation.
* **No signs of right heart failure**: Cardiac amyloidosis can cause right heart failure, leading to signs such as jugular venous distension, but this patient does not have these findings.

**3. Systemic Amyloidosis with Rheumatoid Arthritis**

* **Well-controlled rheumatoid arthritis**: The patient's rheumatoid arthritis is well-controlled with methotrexate, which might suggest a lower risk of developing amyloidosis.
* **No history of other chronic inflammatory conditions**: Systemic amyloidosis can be associated with other chronic inflammatory conditions, but this patient has no such history.
* **No family history of amyloidosis**: Some forms of amyloidosis have a familial component, but this patient has no such history.
* **Normal liver function tests (not explicitly stated, but implied by the absence of hepatomegaly or liver dysfunction symptoms)**: Systemic amyloidosis can cause liver involvement, leading to abnormal liver function tests, but this patient does not have these findings.
* **Absence of carpal tunnel syndrome**: Systemic amyloidosis can cause carpal tunnel syndrome, but this patient does not have this symptom.","Based on the patient's presentation, laboratory results, and physical examination findings, the final diagnosis is:

**Primary Amyloid Light-Chain (AL) Amyloidosis**

The key findings that support this diagnosis include:

* Elevated serum free light chains, which is a hallmark of AL amyloidosis
* Amyloid deposits on abdominal fat biopsy, which confirms the presence of amyloidosis
* Proteinuria (2+ on urinalysis), which suggests kidney involvement
* Systemic symptoms such as weight loss, fatigue, and peripheral edema, which are common in AL amyloidosis
* Neurological symptoms such as tingling sensations in hands and decreased sensation to light touch in feet, which can occur in AL amyloidosis
* Cardiac involvement, as suggested by the elevated BNP and concentric left ventricular hypertrophy on echocardiogram, which is consistent with cardiac amyloidosis

The patient's 10-year history of rheumatoid arthritis may be a contributing factor to the development of AL amyloidosis, as chronic inflammatory conditions can increase the risk of amyloidosis. However, the presence of elevated serum free light chains and amyloid deposits on biopsy suggests that the patient has a clonal plasma cell disorder, which is the primary driver of the amyloidosis.

The diagnosis of AL amyloidosis has significant implications for the patient's management and prognosis, and further evaluation and treatment by a hematologist and other specialists will be necessary to manage the disease and its complications.","Based on the final diagnosis of Primary Amyloid Light-Chain (AL) Amyloidosis, the following additional steps should be taken:

1. **Hematology consultation**: Refer the patient to a hematologist for further evaluation and management of the underlying clonal plasma cell disorder.
2. **Bone marrow biopsy**: Perform a bone marrow biopsy to assess for the presence of clonal plasma cells and to determine the extent of marrow involvement.
3. **Immunofixation electrophoresis**: Perform immunofixation electrophoresis on the serum and urine to identify the specific type of light chain (kappa or lambda) and to quantify the amount of light chain protein.
4. **Cardiology consultation**: Refer the patient to a cardiologist for further evaluation and management of the cardiac involvement, including consideration of cardiac biomarkers and advanced cardiac imaging.
5. **Nephrology consultation**: Refer the patient to a nephrologist for further evaluation and management of the renal involvement, including consideration of renal biopsy and dialysis.
6. **Neurology consultation**: Refer the patient to a neurologist for further evaluation and management of the neurological symptoms, including consideration of nerve conduction studies and electromyography.
7. **Genetic testing**: Consider genetic testing to evaluate for the presence of genetic mutations that may be associated with AL amyloidosis, such as mutations in the TTR gene.
8. **Family screening**: Screen family members for the presence of AL amyloidosis, as there may be a familial component to the disease.
9. **Treatment planning**: Develop a treatment plan that takes into account the patient's overall health, the extent of organ involvement, and the presence of any comorbidities. Treatment options may include:
* Chemotherapy (e.g., melphalan, dexamethasone)
* Autologous stem cell transplantation
* Immunotherapy (e.g., daratumumab, lenalidomide)
* Supportive care (e.g., diuretics, beta blockers)
10. **Regular follow-up**: Schedule regular follow-up appointments with the patient to monitor their response to treatment, assess for any changes in their condition, and adjust the treatment plan as needed.

By taking these additional steps, the patient can receive comprehensive care and management for their AL amyloidosis, and their quality of life can be improved.","{""Score"":1,""Rationale"":""Student listed only Amyloidosis (including AL, cardiac, systemic), which matches one item in the rubric. No mention of Congestive Cardiac Failure, Chronic Kidney Disease, or Multiple Myeloma, so only 1 point awarded.""}","{""Score"":2,""Rationale"":""The answer includes features of amyloidosis (elevated serum free light chains, amyloid deposits, weight loss, fatigue) matching the Amyloidosis component of the rubric (2 points). It does not explicitly identify Congestive Cardiac Failure, Chronic Kidney Disease, or Multiple Myeloma as listed in the rubric, so no points are awarded for those items.""}","{""Score"":0,""Rationale"":""The answer does not match any of the specific opposing‑finding statements listed in the high‑scoring rubric for Amyloidosis, Congestive Cardiac Failure, CKD, or the biopsy findings for Multiple Myeloma; it provides unrelated opposing points and omits the required diagnoses, so no points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies amyloidosis and cites the key findings (fatigue, edema, proteinuria, neuropathy, and biopsy-confirmed amyloid deposits) that match the high‑scoring example, thus earning full credit.""}","{""Score"":4,""Rationale"":""The answer includes bone marrow biopsy and mentions renal biopsy, matching two of the three required items (each worth 2 points). It does not include Cardiac MRI, so only 4 of the possible 6 points are awarded.""}",9.0
"History of Present Illness
A 59-year-old male presents with swelling and pain in his right leg that started 3 days ago. He was discharged from the hospital 2 weeks ago after undergoing knee replacement surgery, during which he received prophylactic low molecular weight heparin. He reports intermittent fever and recent episodes of palpitations. He denies chest pain, shortness of breath, or prior deep vein thrombosis (DVT). 

  Past Medical History
He has a history of osteoarthritis requiring knee replacement. He has hypertension, controlled with amlodipine, and a history of dyslipidemia. He has no history of malignancy or clotting disorders. 

  Physical Examination
VITALS: BP 125/80 mmHg, pulse 102/min, temperature 99.6°F. 
GEN: Appears mildly uncomfortable. 
CARDIAC: Regular rhythm, no murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender. 
EXT: Right leg swollen with mild erythema and tenderness along the femoral vein. Homans' sign is positive. No ulcers or skin changes. 
SKIN: Petechiae on both forearms. 

  Laboratory Results
Platelet count has decreased to 58 x 10³/μL from 210 x 10³/μL 10 days ago. D-dimer is elevated at 5.2 μg/mL. The Heparin-PF4 antibody test is positive. Ultrasound reveals a thrombus in the right femoral vein.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Heparin-Induced Thrombocytopenia (HIT)**: The patient has a history of recent heparin use, a significant drop in platelet count, and a positive Heparin-PF4 antibody test, which are all consistent with HIT.
2. **Deep Vein Thrombosis (DVT)**: The patient presents with swelling, pain, and erythema in the right leg, and ultrasound confirms a thrombus in the right femoral vein, which is consistent with DVT.
3. **Thromboembolic Disease with Immune-Mediated Thrombocytopenia**: The patient's presentation of thrombosis (DVT) and thrombocytopenia, along with the presence of petechiae and a positive Heparin-PF4 antibody test, could also suggest an immune-mediated thrombocytopenia, potentially related to the recent heparin use or an underlying autoimmune process.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Heparin-Induced Thrombocytopenia (HIT)**

* Recent use of low molecular weight heparin (LMWH) for prophylaxis after knee replacement surgery
* Significant drop in platelet count (from 210 x 10³/μL to 58 x 10³/μL) within 10 days of heparin initiation
* Positive Heparin-PF4 antibody test, which is a specific test for HIT
* Presence of thrombosis (DVT) despite heparin prophylaxis, which is a paradoxical feature of HIT
* Timing of thrombocytopenia and thrombosis is consistent with HIT, which typically occurs 5-10 days after heparin initiation

**2. Deep Vein Thrombosis (DVT)**

* Recent surgery (knee replacement) and hospitalization, which are risk factors for DVT
* Swelling, pain, and erythema in the right leg, which are classic symptoms of DVT
* Positive Homans' sign, which is a physical examination finding suggestive of DVT
* Elevated D-dimer level (5.2 μg/mL), which is a sensitive but non-specific test for DVT
* Ultrasound confirmation of a thrombus in the right femoral vein, which is diagnostic of DVT

**3. Thromboembolic Disease with Immune-Mediated Thrombocytopenia**

* Presence of thrombosis (DVT) and thrombocytopenia, which could suggest an underlying immune-mediated process
* Petechiae on both forearms, which could indicate a bleeding tendency or immune-mediated thrombocytopenia
* Recent surgery and hospitalization, which could trigger an immune response and increase the risk of thrombosis
* Positive Heparin-PF4 antibody test, which could suggest an immune-mediated response to heparin
* However, this diagnosis is less likely than HIT, as the patient's presentation and laboratory findings are more consistent with HIT than a primary immune-mediated thrombocytopenia.","Here are the findings that oppose or do not support each of the possible diagnoses:

**1. Heparin-Induced Thrombocytopenia (HIT)**

* The patient's platelet count did not drop to a level typically seen in HIT (usually < 20 x 10³/μL) before the diagnosis was made, although a 50% drop from baseline is also consistent with HIT.
* The patient does not have a history of previous thrombocytopenia or bleeding disorders, which can sometimes be seen in patients with HIT.
* No other signs of systemic inflammation or immune activation, such as elevated erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP), are mentioned, although these are not specific findings.
* The patient's vital signs, such as blood pressure and temperature, are relatively stable, which does not suggest a severe systemic reaction.

**2. Deep Vein Thrombosis (DVT)**

* The patient does not have a history of previous DVT or pulmonary embolism (PE), which can increase the risk of recurrent thrombosis.
* No mention of other risk factors for DVT, such as cancer, nephrotic syndrome, or inherited thrombophilias, which can increase the risk of thrombosis.
* The patient's symptoms of DVT, such as swelling and pain, are relatively mild, and the patient does not have any signs of phlegmasia cerulea dolens (a severe form of DVT).
* The patient's D-dimer level is elevated, but not extremely high, which could suggest a smaller or more distal thrombus.

**3. Thromboembolic Disease with Immune-Mediated Thrombocytopenia**

* The patient's presentation and laboratory findings are more consistent with HIT than a primary immune-mediated thrombocytopenia, such as immune thrombocytopenic purpura (ITP).
* No other signs of immune-mediated disease, such as autoimmune hemolytic anemia or rheumatoid arthritis, are mentioned.
* The patient's petechiae are not widespread or severe, which could suggest a milder bleeding tendency.
* The patient's platelet count drop is significant, but it is not as severe as typically seen in primary immune-mediated thrombocytopenia, and the patient does not have a history of bleeding disorders or easy bruising.

Note that these opposing findings do not necessarily rule out each diagnosis, but rather provide a more nuanced understanding of the patient's presentation and the potential limitations of each diagnosis.","Based on the patient's presentation, laboratory findings, and risk factors, the final diagnosis is:

**Heparin-Induced Thrombocytopenia (HIT)**

The patient's recent use of low molecular weight heparin (LMWH) for prophylaxis after knee replacement surgery, significant drop in platelet count, positive Heparin-PF4 antibody test, and presence of thrombosis (DVT) despite heparin prophylaxis are all consistent with HIT. The patient's presentation and laboratory findings meet the 4Ts scoring system for HIT, which includes:

* Thrombocytopenia: significant drop in platelet count (score: 2)
* Timing: thrombocytopenia occurred 5-10 days after heparin initiation (score: 2)
* Thrombosis: presence of DVT (score: 2)
* Other causes: no other obvious cause for thrombocytopenia (score: 1)

The total score is 7, which is consistent with a high probability of HIT.

The patient's DVT is likely a complication of HIT, and the petechiae on both forearms may be related to the thrombocytopenia. The patient's intermittent fever and palpitations may be related to the underlying inflammatory response or thrombosis.

It is essential to immediately discontinue all forms of heparin, including LMWH, and initiate alternative anticoagulation therapy, such as a direct thrombin inhibitor (e.g., argatroban) or a factor Xa inhibitor (e.g., fondaparinux), to prevent further thrombosis and manage the patient's HIT.","Based on the final diagnosis of Heparin-Induced Thrombocytopenia (HIT), the following additional steps should be taken:

1. **Discontinue all forms of heparin**: Immediately stop all heparin products, including low molecular weight heparin (LMWH), to prevent further platelet activation and thrombosis.
2. **Initiate alternative anticoagulation therapy**: Start a direct thrombin inhibitor (e.g., argatroban) or a factor Xa inhibitor (e.g., fondaparinux) to prevent further thrombosis and manage the patient's HIT.
3. **Monitor platelet count**: Closely monitor the patient's platelet count to assess the response to treatment and adjust the anticoagulation therapy as needed.
4. **Assess for thrombosis extension or recurrence**: Regularly assess the patient for signs and symptoms of thrombosis extension or recurrence, such as worsening leg swelling, pain, or shortness of breath.
5. **Consider warfarin initiation**: Once the patient's platelet count has recovered (usually > 150 x 10³/μL), consider initiating warfarin therapy to provide long-term anticoagulation.
6. **Avoid platelet transfusions**: Unless the patient has a life-threatening bleeding complication, avoid platelet transfusions, as they may worsen the thrombocytopenia and increase the risk of thrombosis.
7. **Provide patient education**: Educate the patient on the risks and benefits of anticoagulation therapy, the importance of monitoring, and the signs and symptoms of thrombosis or bleeding complications.
8. **Consult a hematologist**: Consider consulting a hematologist for guidance on managing the patient's HIT and anticoagulation therapy, particularly if the patient has a complex medical history or requires long-term anticoagulation.
9. **Document the patient's allergy to heparin**: Document the patient's allergy to heparin in their medical record to prevent future exposure to heparin products.
10. **Consider reporting the adverse event**: Report the adverse event to the relevant authorities, such as the hospital's quality improvement department or the manufacturer of the heparin product, to help improve patient safety and prevent similar events in the future.

By taking these additional steps, the patient's HIT can be effectively managed, and the risk of further thrombosis or bleeding complications can be minimized.","{""Score"":2,""Rationale"":""The answer includes Heparin-Induced Thrombocytopenia (HIT) and Deep Vein Thrombosis (DVT), which match two of the three required concepts. The third listed diagnosis (Thromboembolic Disease with Immune-Mediated Thrombocytopenia) does not match the required third concept (Fat embolism), so no point is awarded for it.""}","{""Score"":4,""Rationale"":""The answer correctly identifies Heparin-Induced Thrombocytopenia and Deep Vein Thrombosis with appropriate supporting details, matching two rubric items (2 points each). However, the third diagnosis presented is 'Thromboembolic Disease with Immune-Mediated Thrombocytopenia' instead of the required Fat Embolism, so no points are awarded for that category.""}","{""Score"":0,""Rationale"":""Student answer does not match any of the concepts listed in the high scoring example for HIT, DVT, or Fat Embolism, so no points awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Heparin-Induced Thrombocytopenia (HIT) and provides the key supporting features (new thrombosis, thrombocytopenia, recent heparin use, positive Heparin-PF4 antibody test, petechiae) that match the high‑scoring example.""}","{""Score"":6,""Rationale"":""The answer includes all three required concepts: discontinuing all heparin products, starting alternative anticoagulation (argatroban or fondaparinux), and closely monitoring platelet count, each worth 2 points.""}",14.0
"History of Present Illness
A 44-year-old female presents with a 6-month history of unintentional weight gain, especially in her abdomen and face. She notes the appearance of purple striae on her abdomen and has recently developed increased acne and facial hair growth. She reports fatigue, insomnia, and mood swings. Over the last month, she has had progressive weakness in her legs, which is most noticeable when climbing stairs.

Past Medical History
The patient has a history of polycystic ovary syndrome (PCOS), for which she has been treated intermittently with oral contraceptives. She denies any history of diabetes or previous steroid use.

Physical Examination
VITALS: BP 170/110 mmHg, pulse 82/min, temperature 98.5°F.
GEN: Overweight, with moon facies and a central distribution of fat.
CARDIAC: Regular rhythm, no murmurs.
PULM: Clear to auscultation bilaterally.
ABD: Obese with prominent abdominal striae and a rounded abdomen.
EXT: Bilateral proximal muscle weakness, especially in the thighs.
SKIN: Purple striae on the abdomen, mild acne on the back and face.

Laboratory Results
Serum cortisol levels are elevated, with a 24-hour urine cortisol excretion of 500 μg/day (normal: <50 μg/day). ACTH is raised, and MRI of the pituitary gland shows a small adenoma.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Cushing's Syndrome**: The patient's symptoms such as weight gain, particularly in the abdominal and facial areas, purple striae, acne, facial hair growth, and muscle weakness are consistent with Cushing's syndrome. The elevated serum cortisol levels and 24-hour urine cortisol excretion also support this diagnosis.
2. **Cushing's Disease**: The presence of a pituitary adenoma on MRI, elevated ACTH, and elevated cortisol levels suggest that the patient may have Cushing's disease, which is a specific type of Cushing's syndrome caused by an ACTH-secreting pituitary tumor.
3. **Adrenal Cushing's Syndrome (less likely)**: Although less likely given the elevated ACTH levels, adrenal Cushing's syndrome is still a possible diagnosis. This condition is caused by excess cortisol production by the adrenal glands, which could be due to an adrenal tumor or hyperplasia. However, the presence of a pituitary adenoma and elevated ACTH levels make this diagnosis less likely.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Cushing's Syndrome**

* Supportive findings:
	+ Weight gain, particularly in the abdominal and facial areas (central obesity)
	+ Purple striae on the abdomen
	+ Acne and facial hair growth (hirsutism)
	+ Proximal muscle weakness
	+ Elevated serum cortisol levels and 24-hour urine cortisol excretion
	+ Hypertension (BP 170/110 mmHg)
* Risk factors:
	+ None mentioned in the history, but the patient's history of polycystic ovary syndrome (PCOS) may be a contributing factor, as some studies suggest a link between PCOS and Cushing's syndrome

**2. Cushing's Disease**

* Supportive findings:
	+ Elevated ACTH levels, which suggest that the excess cortisol production is driven by an ACTH-secreting tumor
	+ Presence of a small pituitary adenoma on MRI, which is consistent with an ACTH-secreting pituitary tumor
	+ Symptoms consistent with Cushing's syndrome, such as weight gain, striae, acne, and muscle weakness
	+ Elevated serum cortisol levels and 24-hour urine cortisol excretion
* Risk factors:
	+ None mentioned in the history, but the patient's age and sex (44-year-old female) are consistent with the typical demographic for Cushing's disease

**3. Adrenal Cushing's Syndrome (less likely)**

* Supportive findings:
	+ Elevated serum cortisol levels and 24-hour urine cortisol excretion, which suggest excess cortisol production
	+ Symptoms consistent with Cushing's syndrome, such as weight gain, striae, acne, and muscle weakness
* Risk factors:
	+ None mentioned in the history, but a family history of adrenal tumors or hyperplasia could be a risk factor
	+ However, the presence of a pituitary adenoma and elevated ACTH levels make this diagnosis less likely, as adrenal Cushing's syndrome is typically associated with low or undetectable ACTH levels.

Note that the presence of a pituitary adenoma and elevated ACTH levels make Cushing's disease a more likely diagnosis than adrenal Cushing's syndrome.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Cushing's Syndrome**

* Opposing findings:
	+ The patient's symptoms have developed over a relatively short period (6 months), whereas Cushing's syndrome often develops over a longer period.
	+ The patient's potassium levels are not mentioned, but hypokalemia is a common finding in Cushing's syndrome, particularly if the patient has ectopic ACTH production.
* Expected findings not present:
	+ Hyperglycemia: Cushing's syndrome is often associated with glucose intolerance or diabetes, but the patient's glucose levels are not mentioned.
	+ Osteoporosis: Cushing's syndrome can cause osteoporosis, but there is no mention of bone density testing or osteoporotic fractures.
	+ Poor wound healing: Cushing's syndrome can impair wound healing, but there is no mention of delayed healing or poor wound closure.

**2. Cushing's Disease**

* Opposing findings:
	+ The patient's ACTH levels are elevated, but not extremely high, which might be expected in a patient with a large ACTH-secreting pituitary tumor.
	+ The patient's pituitary adenoma is described as small, which might not be expected to produce sufficient ACTH to cause the patient's symptoms.
* Expected findings not present:
	+ Visual field defects: A pituitary adenoma can cause visual field defects, particularly if it is large or has extended into the suprasellar region, but there is no mention of visual symptoms.
	+ Headaches: Pituitary adenomas can cause headaches, but there is no mention of headache symptoms.
	+ Menstrual irregularities: Cushing's disease can cause menstrual irregularities, but the patient's history of PCOS might make it difficult to assess menstrual function.

**3. Adrenal Cushing's Syndrome (less likely)**

* Opposing findings:
	+ Elevated ACTH levels, which suggest that the excess cortisol production is driven by an ACTH-secreting tumor, rather than an adrenal tumor.
	+ The presence of a pituitary adenoma, which is not typically associated with adrenal Cushing's syndrome.
* Expected findings not present:
	+ Low or undetectable ACTH levels: Adrenal Cushing's syndrome is typically associated with low or undetectable ACTH levels, but the patient's ACTH levels are elevated.
	+ Adrenal mass: Adrenal Cushing's syndrome is often caused by an adrenal tumor, but there is no mention of an adrenal mass on imaging studies.
	+ Virilization: Adrenal Cushing's syndrome can cause virilization in females, particularly if the tumor produces androgens, but there is no mention of virilizing symptoms such as clitoromegaly or deepening of the voice.","Based on the patient's symptoms, physical examination, laboratory results, and imaging studies, the final diagnosis is:

**Cushing's Disease**

The diagnosis of Cushing's disease is supported by the following findings:

* Elevated serum cortisol levels and 24-hour urine cortisol excretion, which indicate excess cortisol production
* Elevated ACTH levels, which suggest that the excess cortisol production is driven by an ACTH-secreting tumor
* Presence of a small pituitary adenoma on MRI, which is consistent with an ACTH-secreting pituitary tumor
* Symptoms consistent with Cushing's syndrome, such as weight gain, striae, acne, and muscle weakness
* Hypertension and glucose intolerance are also common in Cushing's disease, and the patient's blood pressure is elevated

The patient's history of polycystic ovary syndrome (PCOS) may be a contributing factor, as some studies suggest a link between PCOS and Cushing's syndrome. However, the presence of a pituitary adenoma and elevated ACTH levels make Cushing's disease the most likely diagnosis.

The diagnosis of Cushing's disease has significant implications for the patient's management and treatment. The patient will likely require surgical removal of the pituitary adenoma, followed by medical therapy to manage any residual symptoms or hormonal imbalances. Close monitoring of the patient's blood pressure, glucose levels, and electrolytes will also be necessary to prevent complications.

In terms of specific treatment options, the patient may be considered for:

* Transsphenoidal surgery to remove the pituitary adenoma
* Medical therapy with glucocorticoid receptor antagonists or other medications to manage symptoms and prevent complications
* Close monitoring of the patient's blood pressure, glucose levels, and electrolytes to prevent complications

Overall, the diagnosis of Cushing's disease requires a comprehensive treatment approach that addresses the patient's hormonal imbalances, manages symptoms, and prevents complications.","Based on the diagnosis of Cushing's disease, the following additional steps should be taken:

1. **Confirmatory testing**: Perform a high-dose dexamethasone suppression test to confirm the diagnosis of Cushing's disease. This test can help differentiate between Cushing's disease and other forms of Cushing's syndrome.
2. **Pituitary MRI with contrast**: Perform a pituitary MRI with contrast to better visualize the pituitary adenoma and assess its size, location, and relationship to surrounding structures.
3. **Visual field testing**: Perform visual field testing to assess for any visual field defects that may be caused by the pituitary adenoma.
4. **Endocrine evaluation**: Perform a comprehensive endocrine evaluation to assess the patient's hormonal status, including:
	* Thyroid function tests (TSH, free T4, free T3)
	* Gonadotropin levels (LH, FSH)
	* Prolactin level
	* Insulin-like growth factor-1 (IGF-1) level
5. **Bone density testing**: Perform bone density testing (e.g., DEXA scan) to assess the patient's risk of osteoporosis and fractures.
6. **Sleep study**: Consider performing a sleep study to assess for sleep apnea, which is common in patients with Cushing's disease.
7. **Psychiatric evaluation**: Consider performing a psychiatric evaluation to assess for any mood or cognitive disorders that may be related to Cushing's disease.
8. **Surgical consultation**: Consult with a neurosurgeon to discuss the possibility of surgical removal of the pituitary adenoma.
9. **Medical management**: Initiate medical management to control the patient's symptoms and prevent complications, including:
	* Glucocorticoid receptor antagonists (e.g., mifepristone)
	* Medications to control blood pressure and glucose levels
	* Medications to manage mood and cognitive symptoms
10. **Follow-up**: Schedule regular follow-up appointments to monitor the patient's response to treatment, adjust medications as needed, and assess for any complications or side effects.

By taking these additional steps, the patient's diagnosis of Cushing's disease can be confirmed, and a comprehensive treatment plan can be developed to manage their symptoms and prevent complications.","{""Score"":2,""Rationale"":""The answer includes Cushing's Syndrome and Cushing's Disease, which match two of the three concepts in the rubric. It does not include Polycystic Ovary Syndrome or Exogenous Steroids, and adds an unrelated diagnosis, so only two points are awarded.""}","{""Score"":4,""Rationale"":""Student correctly identified Cushing's Disease and Cushing's Syndrome with matching findings, earning 4 points. PCOS was omitted and an extra adrenal Cushing's diagnosis not in rubric, so no points for those.""}","{""Score"":0,""Rationale"":""The response does not match any of the concepts or specific opposing/supporting findings listed in the high‑scoring example. It introduces an unrelated diagnosis (Adrenal Cushing's Syndrome) and provides opposing findings that contradict the rubric’s criteria, resulting in zero points.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Cushing's Disease and includes the key features from the high‑scoring example (weight gain, striae, elevated cortisol, ACTH findings, pituitary adenoma on MRI), thus meeting the rubric criteria for full credit.""}","{""Score"":2,""Rationale"":""The answer includes a dexamethasone suppression test, matching one rubric item, but does not mention ACTH measurement or referral to endocrinology, so only 2 of the 6 points are earned.""}",10.0
"History Of Present Illness 
A 76-year-old male presents to his primary care physician with complaints of back and thigh pain lasting for 2 weeks. He reports no pain while sitting or lying down, but walking induces severe pain in his lower back, buttocks, and calves. He also feels fatigued and slightly febrile. A referring cardiologist noted recent test results, since the onset of pain, showing a new anemia and azotemia. Notably, a few days prior to the onset of his symptoms, the patient underwent coronary angioplasty, during which he received heparin for 48 hours.
Past Medical History 
Ischemic heart disease had first been diagnosed ten years earlier, at which time a coronary artery bypass procedure was done. 
Physical Examination 
VITALS: 99.6° F.; pulse was 94/min and regular; BP was 110/88 mmHg. 
GEN: Well appearing 
CARDS: There is a grade III/VI apical systolic murmur. 
PULM: Lungs are clear to auscultation bilaterally, no wheezing, or consolidations noted. 
ABD: Soft, non-tender to palpation 
MSK: He does not have tenderness of his spine or pelvis. Spinal mobility is normal, as is the mobility of his hips. Standing is painless; however, pain is experienced in his low back, buttocks and calves within a minute of feeble running in place. The pain disappears shortly after exercise is discontinued. 
EXT: Peripheral pulses were symmetrically reduced, but palpable. The neurological examination was normal. 
SKIN: Patient has a purple, red, lacy rash over his low back and buttocks. 
Laboratory 
WBC of 11.5 x 103 cells /μL; differential of 64% segs, 20% lymphocytes, 3% monocytes, 12% eosinophils and 1% basophil. The hematocrit was 28% and the platelet count was 315 x 103 /μL. The erythrocyte sedimentation rate was 99 mm/h. Urinalysis was normal except for 2+ proteinuria. Serum creatinine was 4.0 mg/dL; sodium was 145 mEq/L; potassium 4.0 mEq/L; chloride 105 mEq/L. SGOT was 27 U/L; GGT was 90 U/L; alkaline phosphatase was 153 U/L.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Aortoiliac Occlusive Disease**: The patient's symptoms of back and thigh pain that worsen with walking (claudication) and improve with rest, along with the presence of a purple, red, lacy rash over his low back and buttocks, suggest a possible diagnosis of aortoiliac occlusive disease. The reduced peripheral pulses and elevated erythrocyte sedimentation rate (ESR) also support this diagnosis.
2. **Cholesterol Crystal Embolization (CCE)**: The patient's recent history of coronary angioplasty and heparin use, along with the development of acute kidney injury (azotemia) and anemia, raise the possibility of cholesterol crystal embolization. The presence of eosinophilia (12% eosinophils) and elevated ESR also support this diagnosis.
3. **Vasculitis (e.g. Giant Cell Arteritis or Polyarteritis Nodosa)**: The patient's age, symptoms of back and thigh pain, fatigue, and fever, along with the presence of a purple, red, lacy rash and elevated inflammatory markers (ESR and WBC), suggest a possible diagnosis of vasculitis. The presence of anemia, azotemia, and proteinuria also support this diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Aortoiliac Occlusive Disease**

* Supportive findings:
	+ Claudication symptoms: The patient experiences severe pain in his lower back, buttocks, and calves when walking, which improves with rest.
	+ Reduced peripheral pulses: The patient has symmetrically reduced peripheral pulses, which suggests impaired blood flow to the lower extremities.
	+ Age: The patient is 76 years old, which is a common age range for the development of aortoiliac occlusive disease.
	+ History of ischemic heart disease: The patient has a history of ischemic heart disease, which increases the risk of developing peripheral arterial disease, including aortoiliac occlusive disease.
* Risk factors:
	+ Smoking (not mentioned, but common in patients with ischemic heart disease)
	+ Hypertension (not mentioned, but common in patients with ischemic heart disease)
	+ Hyperlipidemia (not mentioned, but common in patients with ischemic heart disease)
	+ Diabetes (not mentioned, but common in patients with ischemic heart disease)

**2. Cholesterol Crystal Embolization (CCE)**

* Supportive findings:
	+ Recent coronary angioplasty and heparin use: The patient underwent coronary angioplasty and received heparin for 48 hours, which increases the risk of cholesterol crystal embolization.
	+ Acute kidney injury (azotemia): The patient has a serum creatinine of 4.0 mg/dL, which suggests acute kidney injury.
	+ Anemia: The patient has a hematocrit of 28%, which suggests anemia.
	+ Eosinophilia: The patient has 12% eosinophils, which is a common finding in cholesterol crystal embolization.
* Risk factors:
	+ Age: The patient is 76 years old, which increases the risk of cholesterol crystal embolization.
	+ History of ischemic heart disease: The patient has a history of ischemic heart disease, which increases the risk of cholesterol crystal embolization.
	+ Recent invasive vascular procedure (coronary angioplasty): The patient underwent a recent invasive vascular procedure, which increases the risk of cholesterol crystal embolization.

**3. Vasculitis (e.g. Giant Cell Arteritis or Polyarteritis Nodosa)**

* Supportive findings:
	+ Systemic symptoms: The patient has symptoms of fatigue, fever, and weight loss (not mentioned, but common in vasculitis).
	+ Skin rash: The patient has a purple, red, lacy rash over his low back and buttocks, which suggests a vasculitic process.
	+ Elevated inflammatory markers: The patient has an elevated ESR (99 mm/h) and WBC (11.5 x 10^3 cells/μL), which suggests an inflammatory process.
	+ Anemia: The patient has a hematocrit of 28%, which suggests anemia.
* Risk factors:
	+ Age: The patient is 76 years old, which increases the risk of giant cell arteritis.
	+ Sex: The patient is male, which increases the risk of giant cell arteritis.
	+ History of ischemic heart disease: The patient has a history of ischemic heart disease, which may increase the risk of vasculitis.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Aortoiliac Occlusive Disease**

* Opposing findings:
	+ Normal spinal mobility: The patient has normal spinal mobility, which suggests that the pain is not related to spinal stenosis or other spinal conditions.
	+ No tenderness of the spine or pelvis: The patient does not have tenderness of the spine or pelvis, which suggests that the pain is not related to a musculoskeletal condition.
	+ Presence of a purple, red, lacy rash: The patient has a rash that is not typical of aortoiliac occlusive disease, which suggests that there may be another underlying condition.
* Expected findings that are not present:
	+ Intermittent claudication at rest: The patient only experiences pain when walking, but not at rest, which is not typical of severe aortoiliac occlusive disease.
	+ More significant reduction in peripheral pulses: The patient has symmetrically reduced peripheral pulses, but they are still palpable, which suggests that the disease may not be as severe as expected.

**2. Cholesterol Crystal Embolization (CCE)**

* Opposing findings:
	+ Presence of a purple, red, lacy rash: The patient has a rash that is not typical of cholesterol crystal embolization, which suggests that there may be another underlying condition.
	+ Normal urinalysis: The patient has a normal urinalysis, except for 2+ proteinuria, which is not typical of cholesterol crystal embolization, which often presents with hematuria and red blood cell casts.
	+ Absence of livedo reticularis: The patient does not have livedo reticularis, which is a common finding in cholesterol crystal embolization.
* Expected findings that are not present:
	+ More significant kidney dysfunction: The patient has azotemia, but the serum creatinine is not as high as expected in cholesterol crystal embolization, which often presents with more severe kidney dysfunction.
	+ Hypertension: The patient's blood pressure is 110/88 mmHg, which is not elevated, as expected in cholesterol crystal embolization, which often presents with hypertension.

**3. Vasculitis (e.g. Giant Cell Arteritis or Polyarteritis Nodosa)**

* Opposing findings:
	+ Absence of jaw claudication: The patient does not have jaw claudication, which is a common symptom of giant cell arteritis.
	+ Absence of scalp tenderness: The patient does not have scalp tenderness, which is a common finding in giant cell arteritis.
	+ Normal liver function tests: The patient has normal liver function tests, except for a slightly elevated alkaline phosphatase, which is not typical of polyarteritis nodosa, which often presents with abnormal liver function tests.
* Expected findings that are not present:
	+ More significant elevation in inflammatory markers: The patient has an elevated ESR, but it is not as high as expected in vasculitis, which often presents with more significant elevation in inflammatory markers.
	+ Presence of other systemic symptoms: The patient does not have other systemic symptoms, such as weight loss, night sweats, or arthralgias, which are common in vasculitis.","Based on the patient's symptoms, laboratory results, and physical examination findings, the final diagnosis is:

**Cholesterol Crystal Embolization (CCE)**

The diagnosis of CCE is supported by the following findings:

* Recent coronary angioplasty and heparin use, which increases the risk of CCE
* Acute kidney injury (azotemia) and anemia, which are common complications of CCE
* Eosinophilia, which is a common finding in CCE
* Presence of a purple, red, lacy rash, which is consistent with livedo reticularis, a common finding in CCE
* Elevated inflammatory markers, such as ESR and WBC, which suggest an inflammatory response to the emboli

While the patient's symptoms and laboratory results are also consistent with aortoiliac occlusive disease and vasculitis, the recent coronary angioplasty and heparin use, along with the presence of eosinophilia and acute kidney injury, make CCE a more likely diagnosis.

The patient's symptoms and laboratory results can be explained by the embolization of cholesterol crystals from the aorta or other large arteries, which can cause inflammation and damage to the affected tissues. The diagnosis of CCE is further supported by the presence of aortic atheromatosis, which is a common underlying condition in patients with CCE.

Treatment for CCE typically involves supportive care, such as hydration and pain management, as well as measures to prevent further embolization, such as discontinuing anticoagulation therapy and avoiding invasive vascular procedures. In some cases, corticosteroids may be used to reduce inflammation and prevent further tissue damage.","Based on the final diagnosis of Cholesterol Crystal Embolization (CCE), the following additional steps can be taken:

1. **Discontinue anticoagulation therapy**: The patient should be taken off anticoagulation therapy, such as heparin, to prevent further embolization.
2. **Supportive care**: The patient should receive supportive care, such as hydration, pain management, and monitoring of vital signs.
3. **Renal replacement therapy**: The patient may require renal replacement therapy, such as dialysis, to manage acute kidney injury.
4. **Corticosteroids**: Corticosteroids, such as prednisone, may be prescribed to reduce inflammation and prevent further tissue damage.
5. **Avoid invasive vascular procedures**: The patient should avoid invasive vascular procedures, such as angiography or vascular surgery, to prevent further embolization.
6. **Monitor for complications**: The patient should be monitored for complications, such as worsening kidney function, cardiac complications, or neurological symptoms.
7. **Consider statin therapy**: Statin therapy may be considered to reduce the risk of further embolization and to manage underlying atherosclerotic disease.
8. **Lifestyle modifications**: The patient should be advised to make lifestyle modifications, such as quitting smoking, exercising regularly, and managing hypertension and diabetes, to reduce the risk of further cardiovascular events.

**Diagnostic tests**:

1. **Imaging studies**: Imaging studies, such as CT or MRI, may be ordered to evaluate the extent of embolization and to rule out other conditions.
2. **Biopsy**: A biopsy of the affected tissue may be considered to confirm the diagnosis of CCE.
3. **Laboratory tests**: Laboratory tests, such as complete blood count, electrolyte panel, and liver function tests, should be monitored regularly to assess the patient's response to treatment and to detect any potential complications.

**Consultations**:

1. **Nephrology consultation**: A nephrology consultation may be ordered to manage the patient's acute kidney injury and to provide guidance on renal replacement therapy.
2. **Cardiology consultation**: A cardiology consultation may be ordered to manage the patient's underlying cardiovascular disease and to provide guidance on further management.
3. **Vascular surgery consultation**: A vascular surgery consultation may be ordered to evaluate the patient's need for surgical intervention and to provide guidance on further management.","{""Score"":1,""Rationale"":""Only 'Cholesterol Crystal Embolization' matches the rubric's 'Cholesterol embolism'. The other two diagnoses (Aortoiliac Occlusive Disease and Vasculitis) do not correspond to 'Acute interstitial nephritis' or 'Peripheral arterial disease' as listed in the rubric.""}","{""Score"":4,""Rationale"":""Student correctly identified cholesterol embolism features (recent PCI, renal failure, eosinophilia, CAD) and peripheral arterial disease/claudication (pain on ambulation improving with rest). No mention of acute interstitial nephritis, so no points for that component.""}","{""Score"":0,""Rationale"":""The answer does not match any of the specific concepts or opposing findings listed in the high‑scoring example (cholesterol embolism, acute interstitial nephritis, peripheral arterial disease). The provided points differ from those in the rubric, so no points are awarded.""}","{""Score"":2,""Rationale"":""Student correctly identified cholesterol embolism (cholesterol crystal embolization), matching the high‑scoring example.""}","{""Score"":2,""Rationale"":""The answer includes a nephrology consultation, which matches one of the rubric items. It does not mention arterial ultrasound/ABI, urine analysis for casts/eosinophils, or a renal biopsy, so only 2 of the 6 possible points are earned.""}",9.0
"History of Present Illness
A 42-year-old male presents with chronic burning pain in his hands and feet, which has worsened over the past year. He has frequent episodes of abdominal cramping and diarrhea. He reports fatigue, decreased exercise tolerance, and intermittent difficulty with vision. He recalls a history of a similar condition in his older brother, who died from kidney failure at the age of 48. 

Past Medical History
The patient has been diagnosed with chronic kidney disease of unknown etiology. He also has a history of hearing loss and occasional headaches. There is a history of diabetes and hypertension. 

Physical Examination
VITALS: BP 150/90 mmHg, pulse 82/min, temperature 98.6°F. 
GEN: Thin, mildly fatigued. 
HEENT: Corneal opacities visible on slit lamp examination. 
CARDIAC: No murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Non-tender, hepatosplenomegaly noted. 
EXT: Angiokeratomas on the lower abdomen and upper thighs. 
SKIN: No significant rashes. 

Laboratory Results
Serum creatinine is elevated at 2.8 mg/dL. Urinalysis shows 3+ proteinuria with no red blood cells. Alpha-galactosidase A activity in plasma is significantly reduced.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Fabry Disease**: This is a genetic disorder caused by a deficiency of alpha-galactosidase A, which is consistent with the patient's low plasma alpha-galactosidase A activity. The disease can cause chronic burning pain in the hands and feet, gastrointestinal symptoms, fatigue, and kidney disease, all of which are present in this patient.
2. **Diabetic Neuropathy**: The patient's history of diabetes and symptoms of chronic burning pain in the hands and feet, as well as gastrointestinal symptoms, could be consistent with diabetic neuropathy. However, the presence of other symptoms such as corneal opacities and angiokeratomas are not typical of diabetic neuropathy.
3. **Amyloidosis**: This is a group of diseases characterized by the deposition of abnormal proteins (amyloid) in various organs, including the kidneys, gastrointestinal tract, and nerves. The patient's symptoms of chronic pain, gastrointestinal symptoms, and kidney disease could be consistent with amyloidosis, although the presence of angiokeratomas and low alpha-galactosidase A activity are more specific for Fabry disease.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Fabry Disease**

* **Low alpha-galactosidase A activity**: The patient's plasma alpha-galactosidase A activity is significantly reduced, which is a diagnostic hallmark of Fabry disease.
* **Family history**: The patient's older brother died from kidney failure at a young age, which could be consistent with Fabry disease, an X-linked recessive disorder.
* **Chronic burning pain in hands and feet**: This is a common symptom of Fabry disease, caused by the accumulation of globotriaosylceramide (Gb3) in peripheral nerves.
* **Gastrointestinal symptoms**: The patient's episodes of abdominal cramping and diarrhea are consistent with Fabry disease, which can cause gastrointestinal involvement.
* **Corneal opacities**: The patient's corneal opacities visible on slit lamp examination are a common finding in Fabry disease.
* **Angiokeratomas**: The presence of angiokeratomas on the patient's lower abdomen and upper thighs is a characteristic skin lesion of Fabry disease.
* **Kidney disease**: The patient's chronic kidney disease of unknown etiology could be related to Fabry disease, which can cause progressive kidney damage.

**2. Diabetic Neuropathy**

* **History of diabetes**: The patient has a history of diabetes, which is a major risk factor for diabetic neuropathy.
* **Chronic burning pain in hands and feet**: This is a common symptom of diabetic neuropathy, caused by damage to peripheral nerves.
* **Gastrointestinal symptoms**: The patient's episodes of abdominal cramping and diarrhea could be related to diabetic neuropathy, which can cause gastrointestinal involvement.
* **Kidney disease**: The patient's chronic kidney disease could be related to diabetes, which is a major cause of kidney disease.

However, the following findings are not typical of diabetic neuropathy:
* Corneal opacities
* Angiokeratomas
* Low alpha-galactosidase A activity

**3. Amyloidosis**

* **Kidney disease**: The patient's chronic kidney disease could be related to amyloidosis, which can cause kidney damage.
* **Gastrointestinal symptoms**: The patient's episodes of abdominal cramping and diarrhea could be related to amyloidosis, which can cause gastrointestinal involvement.
* **Neuropathic pain**: The patient's chronic burning pain in hands and feet could be related to amyloidosis, which can cause peripheral neuropathy.

However, the following findings are not typical of amyloidosis:
* Low alpha-galactosidase A activity
* Corneal opacities
* Angiokeratomas

Note that amyloidosis is a heterogeneous group of diseases, and the specific type of amyloidosis would need to be determined through further testing.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Fabry Disease**

* **Lack of cardiac involvement**: Fabry disease often causes cardiac involvement, including left ventricular hypertrophy, valvular disease, and arrhythmias. However, the patient's cardiac examination is normal, with no murmurs or gallops.
* **No significant rashes**: While angiokeratomas are present, other skin manifestations of Fabry disease, such as telangiectasias or purpura, are not mentioned.
* **No mention of heat or cold intolerance**: Patients with Fabry disease often experience heat or cold intolerance due to autonomic dysfunction, but this is not mentioned in the patient's history.

However, the presence of low alpha-galactosidase A activity, corneal opacities, and angiokeratomas strongly supports the diagnosis of Fabry disease.

**2. Diabetic Neuropathy**

* **Presence of corneal opacities**: Corneal opacities are not a typical finding in diabetic neuropathy.
* **Presence of angiokeratomas**: Angiokeratomas are not a characteristic skin lesion of diabetic neuropathy.
* **Low alpha-galactosidase A activity**: This is not a finding associated with diabetic neuropathy.
* **Family history of kidney disease**: The patient's family history of kidney disease is not typical of diabetic neuropathy, which is usually associated with a history of diabetes.
* **Absence of typical diabetic neuropathy symptoms**: The patient does not have typical symptoms of diabetic neuropathy, such as numbness, tingling, or weakness in the hands and feet.

These findings suggest that diabetic neuropathy is less likely to be the correct diagnosis.

**3. Amyloidosis**

* **Low alpha-galactosidase A activity**: This is not a finding associated with amyloidosis.
* **Presence of angiokeratomas**: Angiokeratomas are not a characteristic skin lesion of amyloidosis.
* **Corneal opacities**: While corneal opacities can occur in amyloidosis, they are not a typical finding.
* **Lack of macroglossia**: Amyloidosis often causes macroglossia (enlargement of the tongue), which is not mentioned in the patient's examination.
* **No mention of weight loss or malnutrition**: Amyloidosis often causes weight loss and malnutrition due to gastrointestinal involvement, but this is not mentioned in the patient's history.

These findings suggest that amyloidosis is less likely to be the correct diagnosis, and that Fabry disease is a more likely explanation for the patient's symptoms and laboratory findings.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Fabry Disease**

The diagnosis is supported by the following key findings:

1. **Low alpha-galactosidase A activity**: This is a diagnostic hallmark of Fabry disease.
2. **Chronic burning pain in hands and feet**: This is a common symptom of Fabry disease, caused by the accumulation of globotriaosylceramide (Gb3) in peripheral nerves.
3. **Gastrointestinal symptoms**: The patient's episodes of abdominal cramping and diarrhea are consistent with Fabry disease, which can cause gastrointestinal involvement.
4. **Corneal opacities**: The patient's corneal opacities visible on slit lamp examination are a common finding in Fabry disease.
5. **Angiokeratomas**: The presence of angiokeratomas on the patient's lower abdomen and upper thighs is a characteristic skin lesion of Fabry disease.
6. **Kidney disease**: The patient's chronic kidney disease of unknown etiology could be related to Fabry disease, which can cause progressive kidney damage.
7. **Family history**: The patient's older brother died from kidney failure at a young age, which could be consistent with Fabry disease, an X-linked recessive disorder.

The diagnosis of Fabry disease is further supported by the absence of findings that would suggest other diagnoses, such as diabetic neuropathy or amyloidosis. The patient's symptoms and laboratory results are consistent with the typical presentation of Fabry disease, and the diagnosis is confirmed by the low alpha-galactosidase A activity.

**Recommendations for further management:**

1. **Genetic counseling**: The patient and his family should receive genetic counseling to discuss the risks and implications of Fabry disease.
2. **Enzyme replacement therapy**: The patient may be eligible for enzyme replacement therapy (ERT) with alpha-galactosidase A to slow the progression of the disease.
3. **Monitoring of kidney function**: The patient's kidney function should be closely monitored, and he may require dialysis or kidney transplantation in the future.
4. **Pain management**: The patient's chronic pain should be managed with medications and other therapies as needed.
5. **Regular follow-up**: The patient should have regular follow-up appointments with a specialist to monitor his condition and adjust his treatment plan as needed.","Based on the diagnosis of Fabry disease, the following additional steps should be taken:

1. **Confirmatory genetic testing**: Perform genetic testing to confirm the diagnosis of Fabry disease and to identify the specific mutation in the GLA gene.
2. **Family screening**: Screen the patient's family members, particularly males, for Fabry disease to identify other affected individuals.
3. **Cardiac evaluation**: Perform a cardiac evaluation, including an electrocardiogram (ECG), echocardiogram, and cardiac MRI, to assess for cardiac involvement.
4. **Neurological evaluation**: Perform a neurological evaluation to assess for neurological involvement, including peripheral neuropathy and cognitive impairment.
5. **Gastrointestinal evaluation**: Perform a gastrointestinal evaluation to assess for gastrointestinal involvement, including endoscopy and colonoscopy.
6. **Ophthalmological evaluation**: Perform a comprehensive ophthalmological evaluation to assess for corneal opacities, cataracts, and other eye abnormalities.
7. **Auditory evaluation**: Perform an auditory evaluation to assess for hearing loss, which is a common feature of Fabry disease.
8. **Renal evaluation**: Perform a renal evaluation, including a renal ultrasound and kidney function tests, to assess for kidney damage and disease progression.
9. **Enzyme replacement therapy (ERT) initiation**: Initiate ERT with alpha-galactosidase A to slow the progression of the disease.
10. **Pain management**: Develop a pain management plan to address the patient's chronic pain, including medications, physical therapy, and other interventions.
11. **Lifestyle modifications**: Educate the patient on lifestyle modifications to manage Fabry disease, including avoiding extreme temperatures, staying hydrated, and avoiding strenuous exercise.
12. **Regular follow-up**: Schedule regular follow-up appointments with a specialist to monitor the patient's condition, adjust the treatment plan as needed, and address any concerns or questions.

**Additional tests that may be ordered:**

1. **Urinary globotriaosylceramide (Gb3) levels**: To monitor the effectiveness of ERT and disease progression.
2. **Plasma globotriaosylceramide (Gb3) levels**: To monitor the effectiveness of ERT and disease progression.
3. **Cardiac biomarkers**: To assess for cardiac involvement and disease progression.
4. **Renal biomarkers**: To assess for kidney damage and disease progression.
5. **Imaging studies**: To assess for organ involvement, including cardiac, renal, and gastrointestinal involvement.

**Referral to a specialist:**

1. **Geneticist**: To confirm the diagnosis and provide genetic counseling.
2. **Cardiologist**: To evaluate and manage cardiac involvement.
3. **Nephrologist**: To evaluate and manage kidney involvement.
4. **Gastroenterologist**: To evaluate and manage gastrointestinal involvement.
5. **Neurologist**: To evaluate and manage neurological involvement.
6. **Ophthalmologist**: To evaluate and manage eye involvement.
7. **Audiologist**: To evaluate and manage hearing loss.","{""Score"":1.5,""Rationale"":""The answer includes Fabry Disease (matches rubric, 1 mark) and Diabetic Neuropathy (matches rubric, 0.5 mark). No other listed concepts appear in the high‑scoring example.""}","{""Score"":4,""Rationale"":""Student correctly identified Fabry Disease with matching features and diabetic complications, but omitted Alport syndrome and polyarteritis nodosa.""}","{""Score"":0,""Rationale"":""The answer does not match any of the opposing findings listed in the rubric. It provides opposing points for Fabry Disease, Diabetic Neuropathy, and Amyloidosis, none of which are present in the high‑scoring example, resulting in zero points.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Fabry Disease and lists the key clinical features (burning pain, angiokeratomas, corneal opacities, family history, reduced alpha‑galactosidase A activity) that match the high‑scoring example, thus earning full credit.""}","{""Score"":6,""Rationale"":""The answer includes confirmatory genetic testing, initiation of enzyme replacement therapy, and monitoring of renal function, matching all three rubric items.""}",13.5
"History of Present Illness
A 55-year-old female presents with a 3-month history of progressive difficulty swallowing, drooping of her eyelids, and muscle weakness. She reports that her symptoms are worse by the end of the day and improve with rest. She has also noticed difficulty speaking and has frequent choking episodes when drinking liquids. There is no associated pain, and she denies any other systemic symptoms.

  Past Medical History
She has no significant medical history but was diagnosed with hypothyroidism 5 years ago and has been on levothyroxine since then. Family history is unremarkable.

  Physical Examination
VITALS: BP 130/80 mmHg, pulse 75/min, temperature 98.7°F. 
GEN: Well-appearing, no distress. 
HEENT: Ptosis noted in both eyelids, worse on the right side. 
PULM: Clear to auscultation bilaterally. 
NEURO: Proximal muscle weakness
EXT: No edema

  Laboratory Results
Acetylcholine receptor antibodies are positive. Serum creatine kinase (CK) is normal.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Myasthenia Gravis (MG)**: The patient's symptoms of progressive difficulty swallowing, drooping of eyelids (ptosis), muscle weakness, and worsening of symptoms by the end of the day are consistent with MG. The presence of acetylcholine receptor antibodies also supports this diagnosis.
2. **Amyotrophic Lateral Sclerosis (ALS)**: Although less likely, ALS could be considered due to the patient's symptoms of progressive muscle weakness, difficulty speaking, and swallowing. However, the presence of acetylcholine receptor antibodies and the lack of other typical ALS symptoms (e.g., fasciculations, upper motor neuron signs) make this diagnosis less likely.
3. **Lambert-Eaton Myasthenic Syndrome (LEMS)**: This rare autoimmune disorder can present with similar symptoms to MG, including muscle weakness, ptosis, and difficulty swallowing. However, LEMS often has a distinct pattern of symptoms, such as proximal muscle weakness and autonomic dysfunction, which are not prominently featured in this patient's presentation. Additionally, LEMS is often associated with small cell lung cancer, which is not mentioned in the patient's history.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Myasthenia Gravis (MG)**

* **Positive acetylcholine receptor antibodies**: This is a highly specific test for MG, and the presence of these antibodies is a strong indicator of the disease.
* **Fluctuating symptoms**: The patient's symptoms worsen by the end of the day and improve with rest, which is a classic pattern seen in MG.
* **Ptosis and diplopia**: The patient's drooping eyelids (ptosis) and difficulty speaking are common symptoms of MG.
* **Proximal muscle weakness**: The patient's physical examination reveals proximal muscle weakness, which is a typical finding in MG.
* **Absence of other systemic symptoms**: MG is often an isolated condition, and the lack of other systemic symptoms (e.g., fever, weight loss) makes this diagnosis more likely.

**2. Amyotrophic Lateral Sclerosis (ALS)**

* **Progressive muscle weakness**: The patient's symptoms of progressive muscle weakness could be consistent with ALS.
* **Difficulty speaking and swallowing**: The patient's symptoms of dysarthria (difficulty speaking) and dysphagia (difficulty swallowing) are common in ALS.
* **Age of onset**: The patient is 55 years old, which is within the typical age range for ALS.
* **However, several factors argue against ALS**:
	+ The presence of acetylcholine receptor antibodies is not typical of ALS.
	+ The patient's symptoms are more fluctuating and improve with rest, which is not typical of ALS.
	+ The lack of other typical ALS symptoms, such as fasciculations, upper motor neuron signs, and muscle atrophy, makes this diagnosis less likely.

**3. Lambert-Eaton Myasthenic Syndrome (LEMS)**

* **Proximal muscle weakness**: The patient's physical examination reveals proximal muscle weakness, which is a common finding in LEMS.
* **However, several factors argue against LEMS**:
	+ The presence of acetylcholine receptor antibodies is more typical of MG than LEMS (which is often associated with voltage-gated calcium channel antibodies).
	+ The patient's symptoms are more typical of MG, with fluctuating weakness and improvement with rest.
	+ The lack of other typical LEMS symptoms, such as autonomic dysfunction (e.g., dry mouth, impotence) and small cell lung cancer, makes this diagnosis less likely.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Myasthenia Gravis (MG)**

* **Normal serum creatine kinase (CK) levels**: Elevated CK levels are sometimes seen in MG, especially during exacerbations. The normal CK level in this patient does not strongly oppose the diagnosis of MG, but it is a finding that was expected to be potentially elevated.
* **No mention of respiratory muscle involvement**: MG can affect respiratory muscles, leading to respiratory failure. The lack of reported respiratory symptoms or signs (e.g., shortness of breath, respiratory distress) is notable, but it does not strongly oppose the diagnosis of MG.
* **No thymoma or other autoimmune disorders**: While not essential for the diagnosis of MG, the presence of a thymoma or other autoimmune disorders (e.g., thyroid disease, rheumatoid arthritis) can be associated with MG. The patient's hypothyroidism is managed with levothyroxine, but there is no mention of other autoimmune disorders or a thymoma.

**2. Amyotrophic Lateral Sclerosis (ALS)**

* **Presence of acetylcholine receptor antibodies**: This finding is highly unusual in ALS and strongly opposes the diagnosis. ALS is not typically associated with autoimmune antibodies, and the presence of these antibodies suggests an alternative diagnosis, such as MG.
* **Fluctuating symptoms that improve with rest**: ALS symptoms typically progress relentlessly and do not improve with rest. The patient's symptoms worsening by the end of the day and improving with rest are not typical of ALS.
* **Lack of upper motor neuron signs**: ALS is characterized by a combination of upper and lower motor neuron signs. The lack of reported upper motor neuron signs (e.g., hyperreflexia, spasticity, Babinski sign) opposes the diagnosis of ALS.
* **Lack of muscle atrophy or fasciculations**: ALS is often associated with muscle atrophy and fasciculations. The absence of these findings in the patient's physical examination opposes the diagnosis of ALS.

**3. Lambert-Eaton Myasthenic Syndrome (LEMS)**

* **Presence of acetylcholine receptor antibodies**: This finding is more typical of MG than LEMS, which is often associated with voltage-gated calcium channel antibodies. The presence of acetylcholine receptor antibodies opposes the diagnosis of LEMS.
* **Lack of autonomic dysfunction**: LEMS is often associated with autonomic dysfunction (e.g., dry mouth, impotence, orthostatic hypotension). The absence of these symptoms opposes the diagnosis of LEMS.
* **No mention of small cell lung cancer**: LEMS is often paraneoplastic, meaning it is associated with an underlying cancer, typically small cell lung cancer. The absence of reported cancer or paraneoplastic symptoms opposes the diagnosis of LEMS.
* **Symptoms do not typically worsen with repeated use**: LEMS symptoms often worsen with repeated use or activity, whereas the patient's symptoms worsen by the end of the day and improve with rest. This pattern is not typical of LEMS.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Myasthenia Gravis (MG)**

The presence of acetylcholine receptor antibodies, which are highly specific for MG, strongly supports this diagnosis. The patient's symptoms of progressive difficulty swallowing, drooping of eyelids (ptosis), muscle weakness, and difficulty speaking are also consistent with MG. The fluctuating nature of the symptoms, worsening by the end of the day and improving with rest, is a classic pattern seen in MG.

The normal serum creatine kinase (CK) level and the lack of other systemic symptoms (e.g., fever, weight loss) do not strongly oppose the diagnosis of MG. The patient's hypothyroidism, which is managed with levothyroxine, is a separate condition that does not appear to be related to the patient's current symptoms.

The other possible diagnoses, ALS and LEMS, are less likely due to the presence of acetylcholine receptor antibodies and the patient's symptom pattern, which is more consistent with MG.

**Recommendations:**

1. **Initiate treatment with acetylcholinesterase inhibitors**, such as pyridostigmine, to improve muscle strength and reduce symptoms.
2. **Consider thymectomy**, as some patients with MG may benefit from surgical removal of the thymus gland.
3. **Monitor for respiratory muscle involvement** and consider respiratory therapy if necessary.
4. **Schedule follow-up appointments** to assess the patient's response to treatment and adjust the treatment plan as needed.

Note: The patient's diagnosis and treatment plan should be managed by a neurologist or a specialist with expertise in MG.","Based on the final diagnosis of Myasthenia Gravis (MG), the following additional steps can be taken:

**Immediate Steps:**

1. **Initiate treatment with acetylcholinesterase inhibitors**: Start the patient on pyridostigmine, 30-60 mg every 4-6 hours, to improve muscle strength and reduce symptoms.
2. **Monitor for side effects**: Monitor the patient for side effects of pyridostigmine, such as nausea, vomiting, and diarrhea.
3. **Assess respiratory function**: Assess the patient's respiratory function, including forced vital capacity (FVC) and negative inspiratory force (NIF), to determine if respiratory support is needed.

**Short-Term Steps:**

1. **Schedule a follow-up appointment**: Schedule a follow-up appointment with the patient in 1-2 weeks to assess their response to treatment and adjust the treatment plan as needed.
2. **Order additional laboratory tests**: Order additional laboratory tests, such as complete blood count (CBC), electrolyte panel, and liver function tests, to monitor for potential side effects of treatment.
3. **Consider thymectomy**: Consider referring the patient to a thoracic surgeon to discuss the possibility of thymectomy, which may be beneficial for some patients with MG.

**Long-Term Steps:**

1. **Establish a treatment plan**: Establish a long-term treatment plan with the patient, including medication management, physical therapy, and respiratory therapy as needed.
2. **Monitor for disease progression**: Monitor the patient for disease progression, including worsening of symptoms, and adjust the treatment plan as needed.
3. **Consider immunosuppressive therapy**: Consider adding immunosuppressive therapy, such as prednisone or azathioprine, to the patient's treatment plan if they do not respond to acetylcholinesterase inhibitors or if their symptoms worsen over time.

**Referrals:**

1. **Neurologist**: Refer the patient to a neurologist for ongoing management and care.
2. **Thoracic surgeon**: Refer the patient to a thoracic surgeon to discuss the possibility of thymectomy.
3. **Respiratory therapist**: Refer the patient to a respiratory therapist to assess and manage their respiratory function.

**Patient Education:**

1. **Disease education**: Educate the patient about MG, including its symptoms, treatment options, and prognosis.
2. **Medication management**: Educate the patient about their medication regimen, including dosing, side effects, and potential interactions.
3. **Lifestyle modifications**: Educate the patient about lifestyle modifications that can help manage their symptoms, such as getting regular exercise, eating a balanced diet, and getting enough rest.","{""Score"":2,""Rationale"":""The answer includes Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome, which match two of the three rubric items. It does not include Hypothyroid Myopathy and adds ALS, which is not listed, so only 2 points are awarded.""}","{
  ""Score"": 2,
  ""Rationale"": ""The answer correctly identifies Myasthenia Gravis with key supporting concepts (positive acetylcholine receptor antibodies, fluctuating symptoms, ptosis, proximal weakness) matching the rubric, earning 2 points. It does not provide the required LEMS concepts (voltage-gated calcium channel antibodies, facilitation EMG response) nor any hypothyroid myopathy concepts, so no points are awarded for those sections.""
}","{""Score"":0,""Rationale"":""The answer does not match any of the opposing findings specified in the rubric. For Myasthenia Gravis the rubric states 'No opposing findings', but the student lists unrelated findings. For Lambert-Eaton Myasthenic Syndrome the rubric expects specific opposing findings (ptosis, bulbar involvement, lack of EMG facilitation) which are not provided. The student also omits the required opposing findings for Hypothyroid Myopathy and adds an unrelated diagnosis (ALS). Therefore no points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Myasthenia Gravis, citing the key features (ptosis, bulbar weakness, fatigue improving with rest, positive acetylcholine receptor antibodies) that align with the high‑scoring example, thus earning full credit.""}","{""Score"":0,""Rationale"":""The answer does not mention any of the three required items from the rubric (CT/MRI of chest, Edrophonium test, or thyroid function assessment), so no points are awarded.""}",6.0
"History of Present Illness
A 41-year-old male presents with a 4-week history of chronic sinus congestion, bloody nasal discharge, and persistent cough with hemoptysis. He also complains of joint pain and swelling in both knees and ankles. He reports unintentional weight loss of 8 kg over the last 2 months. He denies any recent trauma, travel, or exposure to sick contacts.

  Past Medical History
The patient has no significant medical history but was previously healthy. He has no known drug allergies and does not smoke or drink alcohol.

  Physical Examination
VITALS: BP 120/78 mmHg, pulse 88/min, temperature 99.2°F. 
GEN: Well-appearing but fatigued. 
HEENT: Nasal mucosal ulcerations, bloody discharge from both nostrils. 
PULM: Bilateral rales in the lungs. 
ABD: Soft, non-tender. 
EXT: Swelling in both knees and ankles, with mild erythema. 
SKIN: No rashes.

  Laboratory Results
WBC count is 12.8 x 103/μL, with a mild left shift. ESR is elevated at 75 mm/h. Serum creatinine is 1.5 mg/dL, and urinalysis shows 1+ proteinuria with RBC casts. c-ANCA is positive. Chest CT shows multiple nodular lung infiltrates and cavities.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**: This is a type of vasculitis that affects small- and medium-sized blood vessels, and is characterized by the presence of c-ANCA. The patient's symptoms, such as sinus congestion, bloody nasal discharge, hemoptysis, and kidney involvement (elevated serum creatinine and proteinuria with RBC casts), are consistent with GPA.
2. **Microscopic Polyangiitis (MPA)**: This is another type of vasculitis that affects small blood vessels, and can present with similar symptoms to GPA, including kidney involvement and lung disease. However, MPA is typically associated with p-ANCA rather than c-ANCA, although some cases can be c-ANCA positive.
3. **Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)**: This is a type of vasculitis that is characterized by the presence of asthma, eosinophilia, and vasculitis affecting multiple organ systems. While the patient does not have a history of asthma, the presence of sinus congestion, lung disease, and kidney involvement could be consistent with this diagnosis, although the lack of eosinophilia and other typical features makes it less likely.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

* **c-ANCA positivity**: The patient's positive c-ANCA result is a strong indicator of GPA, as this antibody is found in approximately 80-90% of patients with active GPA.
* **Upper and lower respiratory tract involvement**: The patient's symptoms of chronic sinus congestion, bloody nasal discharge, and hemoptysis are consistent with the typical respiratory tract involvement seen in GPA.
* **Renal involvement**: The patient's elevated serum creatinine, proteinuria, and RBC casts are indicative of kidney involvement, which is a common feature of GPA.
* **Systemic symptoms**: The patient's unintentional weight loss, fatigue, and joint pain are consistent with the systemic nature of GPA.
* **Radiographic findings**: The chest CT showing multiple nodular lung infiltrates and cavities is consistent with the pulmonary involvement seen in GPA.

**2. Microscopic Polyangiitis (MPA)**

* **Renal involvement**: The patient's elevated serum creatinine, proteinuria, and RBC casts are indicative of kidney involvement, which is a common feature of MPA.
* **Pulmonary involvement**: The patient's symptoms of hemoptysis and the chest CT showing multiple nodular lung infiltrates and cavities are consistent with the pulmonary involvement seen in MPA.
* **Systemic symptoms**: The patient's unintentional weight loss, fatigue, and joint pain are consistent with the systemic nature of MPA.
* **Elevated ESR**: The patient's elevated ESR is a non-specific indicator of inflammation, which is consistent with MPA.
* **Note**: The presence of c-ANCA is not typical for MPA, which is usually associated with p-ANCA. However, some cases of MPA can be c-ANCA positive, which makes this diagnosis still possible.

**3. Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)**

* **Asthma-like symptoms**: Although not explicitly stated, the patient's chronic sinus congestion could be interpreted as an asthma-like symptom, which is a common feature of Churg-Strauss Syndrome.
* **Pulmonary involvement**: The patient's symptoms of hemoptysis and the chest CT showing multiple nodular lung infiltrates and cavities are consistent with the pulmonary involvement seen in Churg-Strauss Syndrome.
* **Systemic symptoms**: The patient's unintentional weight loss, fatigue, and joint pain are consistent with the systemic nature of Churg-Strauss Syndrome.
* **Elevated ESR**: The patient's elevated ESR is a non-specific indicator of inflammation, which is consistent with Churg-Strauss Syndrome.
* **Note**: The lack of eosinophilia, a history of asthma, and other typical features of Churg-Strauss Syndrome (such as eosinophilic infiltrates on biopsy) makes this diagnosis less likely.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

* **Lack of granulomatous inflammation on physical examination**: Although the patient has nasal mucosal ulcerations, there is no mention of granulomatous inflammation, which is a hallmark of GPA.
* **No history of destructive sinusitis**: GPA often presents with destructive sinusitis, which is not mentioned in the patient's history.
* **Normal blood pressure**: GPA can cause renal involvement, which may lead to hypertension. However, the patient's blood pressure is normal, which is not typical for GPA with significant renal involvement.
* **Expected but not present:**
	+ Eosinopenia (GPA is often associated with low eosinophil counts)
	+ Hypergammaglobulinemia (GPA is often associated with elevated IgA and IgG levels)

**2. Microscopic Polyangiitis (MPA)**

* **c-ANCA positivity**: As mentioned earlier, MPA is typically associated with p-ANCA, not c-ANCA. The presence of c-ANCA makes MPA less likely.
* **Lack of skin involvement**: MPA often presents with skin involvement, such as purpura or ulcerations, which is not mentioned in the patient's history.
* **No history of neuropathy**: MPA can cause neuropathy, which is not mentioned in the patient's history.
* **Expected but not present:**
	+ Elevated IgA levels (MPA is often associated with elevated IgA levels)
	+ Presence of p-ANCA (MPA is typically associated with p-ANCA)

**3. Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)**

* **Lack of eosinophilia**: Churg-Strauss Syndrome is characterized by significant eosinophilia, which is not mentioned in the patient's laboratory results.
* **No history of asthma**: Churg-Strauss Syndrome often presents with a history of asthma, which is not mentioned in the patient's history.
* **No mention of eosinophilic infiltrates**: Churg-Strauss Syndrome is characterized by eosinophilic infiltrates on biopsy, which is not mentioned in the patient's history.
* **Expected but not present:**
	+ Elevated IgE levels (Churg-Strauss Syndrome is often associated with elevated IgE levels)
	+ Presence of eosinophilic infiltrates on biopsy (a hallmark of Churg-Strauss Syndrome)","Based on the patient's symptoms, laboratory results, and radiographic findings, the final diagnosis is:

**Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

The following findings support this diagnosis:

* Positive c-ANCA result, which is a sensitive and specific marker for GPA
* Upper and lower respiratory tract involvement, including chronic sinus congestion, bloody nasal discharge, and hemoptysis
* Renal involvement, including elevated serum creatinine, proteinuria, and RBC casts
* Systemic symptoms, including unintentional weight loss, fatigue, and joint pain
* Radiographic findings, including multiple nodular lung infiltrates and cavities on chest CT

While the patient's presentation is not entirely typical for GPA (e.g., lack of granulomatous inflammation on physical examination), the combination of clinical and laboratory findings makes GPA the most likely diagnosis.

The patient's positive c-ANCA result, in particular, is a strong indicator of GPA, and the presence of renal involvement and systemic symptoms further supports this diagnosis. The radiographic findings are also consistent with GPA, which can cause pulmonary nodules and cavities.

Treatment for GPA typically involves immunosuppressive therapy, such as cyclophosphamide and rituximab, in combination with glucocorticoids. The patient's treatment plan would depend on the severity of their disease and their response to initial therapy.","Based on the final diagnosis of Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA), the following additional steps would be taken:

1. **Confirmatory testing**:
	* Repeat c-ANCA testing to confirm the initial result and assess for titers.
	* Consider testing for PR3-ANCA (proteinase 3-ANCA) and MPO-ANCA (myeloperoxidase-ANCA) to further support the diagnosis.
2. **Imaging studies**:
	* Sinus CT or MRI to evaluate the extent of sinus involvement and assess for any complications.
	* Chest CT with contrast to further evaluate the lung nodules and cavities.
	* Consider a renal ultrasound or CT to assess for any renal complications.
3. **Laboratory tests**:
	* Complete blood count (CBC) with differential to assess for any cytopenias or eosinophilia.
	* Electrolyte panel to assess for any electrolyte imbalances.
	* Liver function tests (LFTs) to assess for any hepatic involvement.
	* Urinalysis with microscopy to assess for any renal involvement.
4. **Infectious disease workup**:
	* Consider testing for any underlying infections that may have triggered the GPA, such as Staphylococcus aureus or influenza.
5. **Ophthalmologic evaluation**:
	* GPA can cause ocular involvement, including conjunctivitis, scleritis, and orbital granulomas. An ophthalmologic evaluation would be performed to assess for any ocular involvement.
6. **ENT evaluation**:
	* An ear, nose, and throat (ENT) evaluation would be performed to assess for any sinus or nasal involvement and to consider any surgical interventions, such as sinus surgery or nasal septum repair.
7. **Pulmonary evaluation**:
	* A pulmonary evaluation would be performed to assess for any lung involvement and to consider any interventions, such as bronchoscopy or lung biopsy.
8. **Renal evaluation**:
	* A renal evaluation would be performed to assess for any renal involvement and to consider any interventions, such as renal biopsy or dialysis.
9. **Immunosuppressive therapy**:
	* The patient would be started on immunosuppressive therapy, such as cyclophosphamide and rituximab, in combination with glucocorticoids to induce remission.
10. **Follow-up and monitoring**:
* The patient would be closely monitored for any signs of disease flare or complications, including regular laboratory tests, imaging studies, and clinical evaluations.

These additional steps would help to confirm the diagnosis, assess the extent of disease involvement, and guide treatment decisions to induce remission and prevent complications.","{""Score"":1,""Rationale"":""The answer includes Granulomatosis with Polyangiitis (Wegener's), which matches one rubric item. The other two diagnoses (Microscopic Polyangiitis and Eosinophilic Granulomatosis with Polyangiitis) are not listed in the rubric, so no points are awarded for them.""}","{""Score"":2,""Rationale"":""The answer includes the key GPA features listed in the rubric (c-ANCA positivity, sinus congestion, bloody nasal discharge, hemoptysis, lung infiltrates, joint pain, proteinuria with RBC casts), earning 2 points. It does not mention rheumatoid arthritis findings or infectious cause criteria, so no points for those sections.""}","{""Score"":0,""Rationale"":""The answer does not mention the rubric's required diagnoses (GPA, RA, infectious causes) with the supporting/opposing findings as in the high‑scoring example; it lists different conditions and points not present in the rubric, so no points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Granulomatosis with Polyangiitis (GPA) and lists the key supporting findings (sinus involvement, hemoptysis, joint symptoms, c‑ANCA positivity, lung nodules) that match the high‑scoring example.""}","{""Score"":2,""Rationale"":""The answer includes urinalysis, matching the first rubric item, but does not mention referral to a rheumatologist nor joint imaging, so only the first 2‑point item is awarded.""}",7.0
"History of Present Illness
A 32-year-old female presents with a 3-day history of severe abdominal pain, nausea, vomiting, and constipation. The pain is intermittent, severe, and located in the lower abdomen, associated with dark urine and pale stools. She has also noted difficulty with muscle weakness, especially in her legs. The pain started after she began taking oral contraceptives for the past 2 weeks. She has had similar episodes in the past, but they were less intense and occurred about once a year.

  Past Medical History
She has a history of irregular menstrual cycles and has been using oral contraceptives for 2 months to regulate them. There is no significant family history of bleeding or liver disorders. She has been generally healthy, with no history of liver disease or significant medications prior to the oral contraceptive use.

  Physical Examination
VITALS: BP 120/75 mmHg, pulse 85/min, temperature 98.9°F. 
GEN: Appears in moderate distress, pale. 
CARDIAC: Regular rhythm, no murmurs. 
PULM: Clear to auscultation bilaterally. 
ABD: Diffuse tenderness to palpation in the lower abdomen with no rebound tenderness. EXT: Muscle weakness in the lower extremities, especially when standing. 
SKIN: No rashes, but urine is dark brown in color.

  Laboratory Results
Urine porphyrin levels are markedly elevated. Serum sodium is low at 130 mEq/L, and liver function tests are normal. Hemoglobin is 11.3 g/dL.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Acute Intermittent Porphyria (AIP)**: The patient's symptoms of severe abdominal pain, nausea, vomiting, constipation, and muscle weakness, along with the elevated urine porphyrin levels, are consistent with AIP. The fact that the symptoms started after taking oral contraceptives, which can trigger AIP attacks, further supports this diagnosis.
2. **Variegate Porphyria**: This type of porphyria can also present with abdominal pain, nausea, vomiting, and muscle weakness, as well as elevated urine porphyrin levels. The patient's pale stools and dark urine also suggest a porphyria disorder, and variegate porphyria is a possibility.
3. **Lead Poisoning**: Although less likely, lead poisoning can cause abdominal pain, constipation, and muscle weakness, as well as elevated urine porphyrin levels (due to the inhibition of heme synthesis). However, the patient's normal liver function tests and the absence of other symptoms such as neuropathy or cognitive impairment make this diagnosis less likely.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Acute Intermittent Porphyria (AIP)**

* **Elevated urine porphyrin levels**: This is a key diagnostic finding for AIP, as it indicates an accumulation of porphyrin precursors in the urine.
* **Severe abdominal pain**: AIP is characterized by recurrent episodes of severe abdominal pain, which is often accompanied by nausea, vomiting, and constipation.
* **Muscle weakness**: Muscle weakness, particularly in the lower extremities, is a common symptom of AIP.
* **Triggered by oral contraceptives**: The patient's symptoms started after taking oral contraceptives, which are known to trigger AIP attacks in susceptible individuals.
* **Normal liver function tests**: AIP is a hepatic porphyria, but liver function tests are often normal between attacks.
* **Family history of similar episodes**: Although the patient does not have a significant family history of bleeding or liver disorders, she has had similar episodes in the past, which suggests a possible genetic component.

**2. Variegate Porphyria**

* **Elevated urine porphyrin levels**: Like AIP, variegate porphyria is characterized by elevated urine porphyrin levels.
* **Abdominal pain and neurological symptoms**: Variegate porphyria can present with abdominal pain, nausea, vomiting, and neurological symptoms such as muscle weakness.
* **Pale stools and dark urine**: The patient's pale stools and dark urine suggest a disorder of heme synthesis, which is consistent with variegate porphyria.
* **Triggered by oral contraceptives**: Like AIP, variegate porphyria can be triggered by oral contraceptives and other hormonal factors.
* **Normal liver function tests**: Variegate porphyria is also a hepatic porphyria, and liver function tests are often normal between attacks.

**3. Lead Poisoning**

* **Elevated urine porphyrin levels**: Lead poisoning can cause an increase in urine porphyrin levels due to the inhibition of heme synthesis.
* **Abdominal pain and constipation**: Lead poisoning can cause abdominal pain, constipation, and other gastrointestinal symptoms.
* **Muscle weakness**: Lead poisoning can cause muscle weakness, particularly in the lower extremities.
* **However, several findings argue against lead poisoning**:
	+ Normal liver function tests: Lead poisoning often causes liver damage and abnormal liver function tests.
	+ No mention of exposure to lead: There is no mention of the patient being exposed to lead through her occupation, environment, or other sources.
	+ No other symptoms of lead poisoning: The patient does not have other symptoms of lead poisoning, such as neuropathy, cognitive impairment, or anemia.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Acute Intermittent Porphyria (AIP)**

* **Normal hemoglobin level**: AIP can cause hemolytic anemia, which would result in a low hemoglobin level. However, the patient's hemoglobin level is 11.3 g/dL, which is slightly low but not significantly anemic.
* **No neurological symptoms**: AIP can cause neurological symptoms such as numbness, tingling, and paralysis, but the patient only reports muscle weakness in the lower extremities.
* **No mental status changes**: AIP can cause mental status changes such as anxiety, depression, and confusion, but the patient does not report any of these symptoms.
* **Normal serum sodium level is not expected to be low**: Although the patient's serum sodium level is low (130 mEq/L), this is not a typical finding in AIP. However, it's worth noting that AIP can cause a variety of electrolyte imbalances.

**2. Variegate Porphyria**

* **No skin manifestations**: Variegate porphyria can cause skin manifestations such as blistering, scarring, and hypertrichosis, but the patient does not report any of these symptoms.
* **No history of photosensitivity**: Variegate porphyria can cause photosensitivity, which would result in skin symptoms after exposure to sunlight. However, the patient does not report any history of photosensitivity.
* **Normal liver function tests are expected, but some liver function tests may be mildly elevated**: While the patient's liver function tests are normal, some patients with variegate porphyria may have mildly elevated liver function tests, even between attacks.
* **Muscle weakness is not as prominent as expected**: Variegate porphyria can cause significant muscle weakness, but the patient's muscle weakness is relatively mild and limited to the lower extremities.

**3. Lead Poisoning**

* **No history of lead exposure**: There is no mention of the patient being exposed to lead through her occupation, environment, or other sources, which makes lead poisoning less likely.
* **Normal liver function tests**: Lead poisoning often causes liver damage and abnormal liver function tests, but the patient's liver function tests are normal.
* **No neuropathy or cognitive impairment**: Lead poisoning can cause neuropathy and cognitive impairment, but the patient does not report any of these symptoms.
* **No anemia**: Lead poisoning can cause anemia, but the patient's hemoglobin level is only slightly low (11.3 g/dL).
* **No renal impairment**: Lead poisoning can cause renal impairment, but the patient's serum creatinine level is not reported, and there is no mention of renal dysfunction.","Based on the patient's symptoms, laboratory results, and physical examination, the final diagnosis is:

**Acute Intermittent Porphyria (AIP)**

The diagnosis of AIP is supported by the following findings:

* Elevated urine porphyrin levels, which are a hallmark of AIP
* Severe abdominal pain, nausea, vomiting, and constipation, which are common symptoms of AIP
* Muscle weakness, particularly in the lower extremities, which is a common symptom of AIP
* Triggering of symptoms by oral contraceptives, which is a known trigger for AIP attacks
* Normal liver function tests, which is consistent with AIP
* Absence of other symptoms that might suggest alternative diagnoses, such as skin manifestations or neuropathy

While variegate porphyria is also a possibility, the patient's symptoms and laboratory results are more consistent with AIP. Lead poisoning is less likely due to the absence of a clear exposure history, normal liver function tests, and lack of other symptoms such as neuropathy or cognitive impairment.

It's worth noting that a definitive diagnosis of AIP would require further testing, such as measurement of erythrocyte porphobilinogen deaminase (PBGD) activity or genetic testing for mutations in the HMBS gene. However, based on the available information, AIP is the most likely diagnosis.","To confirm the diagnosis of Acute Intermittent Porphyria (AIP) and to manage the patient's condition, the following additional steps can be taken:

1. **Measure erythrocyte porphobilinogen deaminase (PBGD) activity**: This enzyme is deficient in AIP, and measuring its activity can help confirm the diagnosis.
2. **Genetic testing**: Genetic testing for mutations in the HMBS gene can help confirm the diagnosis of AIP and identify the specific mutation responsible for the patient's condition.
3. **Measure urine and fecal porphyrins**: Measuring the levels of different porphyrins in the urine and feces can help confirm the diagnosis of AIP and monitor the patient's response to treatment.
4. **Imaging studies**: Imaging studies such as CT or MRI scans may be ordered to rule out other causes of abdominal pain and to evaluate the patient's abdominal organs.
5. **Electrolyte and fluid management**: The patient's electrolyte and fluid status should be closely monitored and managed to prevent complications such as dehydration and electrolyte imbalances.
6. **Pain management**: The patient's pain should be managed with medications such as opioids or other analgesics, and other measures such as relaxation techniques and stress management may be helpful.
7. **Discontinue oral contraceptives**: The patient should be advised to discontinue oral contraceptives, as they may be triggering the AIP attacks.
8. **Consider hospitalization**: If the patient's symptoms are severe or if there are concerns about the patient's ability to manage their condition at home, hospitalization may be necessary to provide close monitoring and management.
9. **Consult a specialist**: A specialist in porphyrias, such as a geneticist or a hepatologist, may be consulted to provide additional guidance and management recommendations.
10. **Develop a treatment plan**: A treatment plan should be developed to manage the patient's AIP, including measures to prevent future attacks, manage symptoms, and monitor the patient's condition over time.

In terms of long-term management, the following steps can be taken:

1. **Avoid triggers**: The patient should be advised to avoid triggers such as oral contraceptives, certain medications, and stress.
2. **Maintain a healthy lifestyle**: The patient should be encouraged to maintain a healthy lifestyle, including a balanced diet, regular exercise, and stress management.
3. **Monitor porphyrin levels**: The patient's porphyrin levels should be monitored regularly to detect any changes or increases in porphyrin levels.
4. **Manage symptoms**: The patient's symptoms should be managed with medications and other measures as needed.
5. **Consider genetic counseling**: If the patient has a family history of AIP or if they are planning to have children, genetic counseling may be recommended to discuss the risks and management of AIP in family members.","{""Score"":0.5,""Rationale"":""The answer includes Acute Intermittent Porphyria (AIP), which matches one of the three concepts in the rubric. The other two diagnoses (Variegate Porphyria and Lead Poisoning) are not listed in the rubric, so no points are awarded for them.""}","{""Score"":1,""Rationale"":""The answer includes the correct features for Acute Intermittent Porphyria, which matches the high‑scoring example. It does not mention Cholecystitis/Gallstones or Irritable Bowel Syndrome, and adds unrelated diagnoses (Variegate Porphyria, Lead Poisoning) that are not in the rubric, so only one of the three possible points is earned.""}","{""Score"":0,""Rationale"":""Student answer does not address the required diagnoses (Gallstones/Cholecystitis and IBS) and provides opposing findings not listed in the rubric; thus no points awarded.""}","{""Score"": 14.5, ""Rationale"": ""Student answer correctly identifies Acute Intermittent Porphyria (AIP) and includes the key concepts from the high scoring example: abdominal pain, muscle weakness, and elevated urine porphyrins, thus meeting all rubric criteria for full credit.""}","{""Score"":2,""Rationale"":""The answer includes genetic testing and discontinuation of oral contraceptives, matching two rubric items, but does not mention IV glucose or hematin infusion, so only 2 of 3 points are awarded.""}",18.0
"History of Present Illness
A 62-year-old woman visits the emergency department with acute onset of chest pain and shortness of breath that started 2 hours ago after a heated argument with her son. She describes the pain as crushing and radiating to her left arm. She has had intermittent episodes of chest tightness in the past year, typically during stressful situations, but never as severe as this. She denies nausea, vomiting, or syncope.

  Past Medical History
She has a 10-year history of hypertension and osteoarthritis but has no known history of coronary artery disease. She is on lisinopril and acetaminophen. She has no family history of cardiac conditions or sudden death. She denies smoking or alcohol use.

  Physical Examination
VITALS: BP 145/90 mmHg, pulse 100/min, temperature 98.4°F. 
GEN: Mildly anxious, diaphoretic. 
CARDIAC: Tachycardic, no murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Non-tender, no hepatosplenomegaly. 
EXT: No cyanosis or edema. 
SKIN: Warm and dry.

  Laboratory Results
Troponin I is elevated at 3.5 ng/mL. Serum brain natriuretic peptide (BNP) is 280 pg/mL. Electrocardiogram (ECG) shows ST-segment elevation in leads V2-V4. ",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Acute Myocardial Infarction (MI)**: The patient's symptoms of crushing chest pain radiating to the left arm, shortness of breath, and elevated troponin I level are consistent with an acute MI. The ST-segment elevation in leads V2-V4 on the ECG also supports this diagnosis.
2. **Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**: The patient's symptoms started after a heated argument, which could be a stress trigger. The presence of chest pain, shortness of breath, and elevated troponin I level, along with the absence of a clear history of coronary artery disease, could suggest Takotsubo cardiomyopathy.
3. **Acute Coronary Syndrome (ACS) with possible Unstable Angina or Non-ST-Elevation MI**: Although the ECG shows ST-segment elevation, the patient's symptoms and laboratory results could also be consistent with unstable angina or a non-ST-elevation MI, particularly given her history of hypertension and intermittent episodes of chest tightness during stressful situations.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Acute Myocardial Infarction (MI)**

* Supporting findings:
	+ Elevated troponin I level (3.5 ng/mL), which is a specific marker for cardiac damage
	+ ST-segment elevation in leads V2-V4 on the ECG, which is a classic sign of an acute MI
	+ Crushing chest pain radiating to the left arm, which is a typical symptom of an MI
	+ Shortness of breath, which can occur due to decreased cardiac output and pulmonary congestion
* Risk factors:
	+ 10-year history of hypertension, which increases the risk of developing coronary artery disease and MI
	+ Age (62 years), which is a risk factor for cardiovascular disease
	+ Stressful situation (heated argument), which can trigger an MI in susceptible individuals

**2. Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**

* Supporting findings:
	+ Acute onset of symptoms after a stressful event (heated argument), which is a classic trigger for Takotsubo cardiomyopathy
	+ Elevated troponin I level (3.5 ng/mL), which can occur in Takotsubo cardiomyopathy due to cardiac stunning
	+ Absence of a clear history of coronary artery disease, which makes Takotsubo cardiomyopathy more likely
	+ Presence of chest pain and shortness of breath, which are common symptoms of Takotsubo cardiomyopathy
* Risk factors:
	+ Female sex, which is a risk factor for Takotsubo cardiomyopathy (70-80% of cases occur in postmenopausal women)
	+ Age (62 years), which is a risk factor for Takotsubo cardiomyopathy (most cases occur in women over 50 years)
	+ Stressful situation (heated argument), which is a common trigger for Takotsubo cardiomyopathy

**3. Acute Coronary Syndrome (ACS) with possible Unstable Angina or Non-ST-Elevation MI**

* Supporting findings:
	+ Intermittent episodes of chest tightness in the past year, which suggests underlying coronary artery disease
	+ Elevated troponin I level (3.5 ng/mL), which can occur in unstable angina or non-ST-elevation MI
	+ Chest pain and shortness of breath, which are common symptoms of ACS
	+ Hypertension, which is a risk factor for coronary artery disease and ACS
* Risk factors:
	+ 10-year history of hypertension, which increases the risk of developing coronary artery disease and ACS
	+ Age (62 years), which is a risk factor for cardiovascular disease
	+ Intermittent episodes of chest tightness, which suggests underlying coronary artery disease and increases the risk of ACS","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Acute Myocardial Infarction (MI)**

* Opposing findings:
	+ The patient's symptoms started after a heated argument, which could suggest a stress-induced cardiomyopathy rather than a traditional MI
	+ The patient has no known history of coronary artery disease, which makes a traditional MI less likely
	+ The patient's ECG shows ST-segment elevation in leads V2-V4, but the elevation is not as pronounced as would be expected in a large MI
* Expected findings that are not present:
	+ Q-waves on the ECG, which are often seen in MIs, but are not present in this case
	+ Significant left ventricular dysfunction on physical examination, such as an S3 heart sound or signs of heart failure, which are not present
	+ A more significant elevation in troponin I level, which would be expected in a larger MI

**2. Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**

* Opposing findings:
	+ The patient's ECG shows ST-segment elevation in leads V2-V4, which is not typical of Takotsubo cardiomyopathy (ECG changes are often more diffuse and nonspecific)
	+ The patient's troponin I level is elevated, but not to the extent that would be expected in a large MI, which could suggest a different diagnosis
	+ The patient has a history of hypertension, which could contribute to coronary artery disease and make a traditional MI more likely
* Expected findings that are not present:
	+ A more significant elevation in BNP level, which is often seen in Takotsubo cardiomyopathy due to the significant left ventricular dysfunction
	+ Signs of left ventricular outflow tract obstruction on physical examination, such as a harsh systolic murmur, which are not present
	+ A more dramatic response to stress, such as a more significant increase in blood pressure or heart rate, which is not seen in this case

**3. Acute Coronary Syndrome (ACS) with possible Unstable Angina or Non-ST-Elevation MI**

* Opposing findings:
	+ The patient's ECG shows ST-segment elevation in leads V2-V4, which is more typical of an ST-elevation MI than unstable angina or non-ST-elevation MI
	+ The patient's troponin I level is elevated, which suggests cardiac damage and is more consistent with an MI than unstable angina
	+ The patient's symptoms are more severe and acute than would be expected in unstable angina, which often presents with more chronic and stable symptoms
* Expected findings that are not present:
	+ Significant ischemic changes on the ECG, such as T-wave inversions or ST-segment depression, which are often seen in unstable angina or non-ST-elevation MI
	+ A history of increasing angina or decreasing exercise tolerance, which would suggest a more chronic coronary artery disease process
	+ Signs of cardiac ischemia on physical examination, such as a new murmur or signs of heart failure, which are not present","Based on the patient's presentation, laboratory results, and ECG findings, the final diagnosis is:

**Acute Myocardial Infarction (ST-Elevation Myocardial Infarction, STEMI)**

The diagnosis is supported by the following findings:

* Crushing chest pain radiating to the left arm, which is a typical symptom of an MI
* Shortness of breath, which can occur due to decreased cardiac output and pulmonary congestion
* Elevated troponin I level (3.5 ng/mL), which is a specific marker for cardiac damage
* ST-segment elevation in leads V2-V4 on the ECG, which is a classic sign of an acute STEMI
* The patient's symptoms and ECG findings are consistent with an acute occlusion of the left anterior descending (LAD) coronary artery, which is a common cause of STEMI.

While the patient's symptoms started after a heated argument, which could suggest a stress-induced cardiomyopathy (Takotsubo cardiomyopathy), the presence of ST-segment elevation and elevated troponin I level make an acute MI more likely. Additionally, the patient's history of hypertension and intermittent episodes of chest tightness suggest underlying coronary artery disease, which increases the risk of an MI.

The patient should be treated with immediate reperfusion therapy, such as primary percutaneous coronary intervention (PCI) or thrombolytic therapy, to restore blood flow to the affected area of the heart. Additionally, the patient should receive standard medical therapy for STEMI, including aspirin, beta blockers, and statins.","Based on the final diagnosis of Acute Myocardial Infarction (STEMI), the following additional steps should be taken:

1. **Activate the Cardiac Catheterization Lab**: Notify the cardiac catheterization lab to prepare for an emergency procedure to perform primary percutaneous coronary intervention (PCI) to restore blood flow to the affected area of the heart.
2. **Administer Aspirin and Other Medications**: Give the patient aspirin (162-325 mg) and other medications such as:
	* Beta blockers (e.g., metoprolol) to reduce heart rate and blood pressure
	* Nitrates (e.g., nitroglycerin) to relieve chest pain and reduce cardiac workload
	* Anticoagulants (e.g., heparin) to prevent further clotting
	* Antiplatelet agents (e.g., clopidogrel) to prevent platelet aggregation
3. **Prepare for Transfer to the Cardiac Catheterization Lab**: Prepare the patient for transfer to the cardiac catheterization lab, including:
	* Ensuring the patient is stable and able to be transported
	* Continuously monitoring the patient's vital signs and ECG
	* Having a defibrillator and other emergency equipment available
4. **Notify the Cardiology Team**: Notify the cardiology team, including the interventional cardiologist and the cardiac catheterization lab staff, to prepare for the emergency procedure.
5. **Continue to Monitor the Patient's Condition**: Continuously monitor the patient's condition, including:
	* Vital signs (blood pressure, heart rate, oxygen saturation)
	* ECG
	* Chest pain and shortness of breath
	* Any changes in the patient's condition should be reported to the cardiology team immediately
6. **Consider Additional Testing**: Consider additional testing, such as:
	* Echocardiogram to assess left ventricular function and wall motion
	* Cardiac biomarkers (e.g., troponin, CK-MB) to assess the extent of cardiac damage
	* Chest X-ray to assess for signs of heart failure or other complications
7. **Develop a Plan for Post-Procedure Care**: Develop a plan for post-procedure care, including:
	* Monitoring the patient's condition in the cardiac intensive care unit (ICU)
	* Managing pain and discomfort
	* Providing education on medication management and lifestyle changes to reduce the risk of future cardiac events.","{""Score"":3,""Rationale"":""Student listed Acute Myocardial Infarction, Takotsubo Cardiomyopathy (stress‑induced cardiomyopathy) and Unstable Angina, matching all three rubric items.""}","{""Score"":6,""Rationale"":""Student identified all three required diagnoses—Takotsubo (Stress‑Induced) Cardiomyopathy, Acute Myocardial Infarction, and Unstable Angina (as part of ACS)—matching the concepts in the rubric, thus earning full marks.""}","{""Score"":0,""Rationale"":""Student answer does not mention any of the key concepts from the rubric (e.g., normal coronary angiography, absence of stenosis, absence of breathlessness, ST elevation supporting Takotsubo, etc.). Therefore no points are awarded.""}","{""Score"":2,""Rationale"":""The response correctly identifies an acute anterior STEMI (Acute Myocardial Infarction, STEMI) and provides the same supporting findings and rationale as the high‑scoring example, matching the required diagnosis and explanation.""}","{""Score"":4,""Rationale"":""Student includes beta‑blocker (partial of supportive care) but omits ACE inhibitor, so no points for item 1. They mention an echocardiogram, matching item 2 (2 points). No psychological support is mentioned, so 0 for item 3. They explicitly notify/ refer to the cardiology team, satisfying item 4 (2 points). Total 4 points.""}",15.0
"History of Present Illness
A 65-year-old male with a history of type 2 diabetes and hypertension presents with a 2-hour history of crushing chest pain radiating to his left arm. He describes the pain as severe and constant, beginning after he climbed a flight of stairs. He is also feeling nauseated and sweaty. He is unable to recall a prior history of similar symptoms. He denies shortness of breath or palpitations but admits to feeling unusually fatigued for the last week.

  Past Medical History
Type 2 diabetes mellitus for 15 years, hypertension for 12 years, and hyperlipidemia. He is on metformin and a statin. He has no history of coronary artery disease or previous myocardial infarctions. He is a smoker (30 pack-years) and drinks alcohol occasionally. Family history is significant for cardiovascular disease, with both parents having had myocardial infarctions in their 50s

  Physical Examination
VITALS: BP 160/90 mmHg, pulse 110 bpm, temperature 98.5°F. 
GEN: Anxious and diaphoretic, in moderate distress due to chest pain. 
CARDIAC: Tachycardic, regular rhythm
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender, no hepatosplenomegaly. 
MSK: No tenderness or joint swelling. 
EXT: No edema. 
SKIN: Diaphoretic, cool extremities.

  Laboratory Results
Troponin I: 3.2 ng/mL (elevated). CBC: Normal. Serum glucose: 180 mg/dL (elevated).",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Acute Myocardial Infarction (MI)**: The patient's symptoms of crushing chest pain radiating to the left arm, nausea, sweating, and elevated troponin I level are consistent with an acute MI.
2. **Unstable Angina**: The patient's chest pain and electrocardiogram (ECG) findings (although not provided) may also suggest unstable angina, which is a precursor to an MI.
3. **Acute Coronary Syndrome (ACS)**: This is a broader diagnosis that encompasses both MI and unstable angina, and is characterized by a sudden reduction in blood flow to the heart, leading to chest pain and other symptoms.

Note: Other diagnoses, such as pulmonary embolism or aortic dissection, are less likely given the patient's presentation, but should still be considered in the differential diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Acute Myocardial Infarction (MI)**

* **Chest pain characteristics**: The patient's chest pain is described as crushing, severe, and constant, which is consistent with the typical presentation of an MI.
* **Radiation to left arm**: The radiation of pain to the left arm is a common feature of MIs, particularly those involving the anterior wall of the heart.
* **Elevated troponin I**: The troponin I level of 3.2 ng/mL is elevated, which is a sensitive and specific marker for myocardial damage.
* **History of risk factors**: The patient has a history of hypertension, hyperlipidemia, and smoking (30 pack-years), which are all significant risk factors for the development of coronary artery disease and MI.
* **Family history**: The patient's family history of cardiovascular disease, with both parents having had MIs in their 50s, also increases his risk of developing an MI.

**2. Unstable Angina**

* **Chest pain characteristics**: While the patient's chest pain is severe and constant, it is also triggered by exertion (climbing a flight of stairs), which is consistent with unstable angina.
* **History of risk factors**: The patient's history of hypertension, hyperlipidemia, and smoking (30 pack-years) also increases his risk of developing unstable angina.
* **Recent fatigue**: The patient's report of feeling unusually fatigued for the last week may indicate a decrease in cardiac function or an increase in cardiac workload, which can be a precursor to unstable angina.
* **Absence of shortness of breath**: The patient denies shortness of breath, which is less common in unstable angina compared to MI.

**3. Acute Coronary Syndrome (ACS)**

* **Chest pain characteristics**: The patient's chest pain is consistent with ACS, which encompasses both MI and unstable angina.
* **Elevated troponin I**: The elevated troponin I level suggests myocardial damage, which is a key feature of ACS.
* **History of risk factors**: The patient's history of hypertension, hyperlipidemia, and smoking (30 pack-years) increases his risk of developing ACS.
* **Electrocardiogram (ECG) findings**: While not provided, an ECG may show signs of ischemia or infarction, which would support the diagnosis of ACS.
* **Clinical presentation**: The patient's overall clinical presentation, including his age, sex, and symptoms, is consistent with ACS.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Acute Myocardial Infarction (MI)**

* **Absence of shortness of breath**: The patient denies shortness of breath, which is a common symptom of MI, particularly if there is associated heart failure or pulmonary edema.
* **Normal pulmonary examination**: The patient's lungs are clear to auscultation bilaterally, which makes pulmonary edema or cardiogenic shock less likely.
* **No reported palpitations**: The patient does not report any palpitations or arrhythmias, which can occur in MI due to reperfusion or ischemia.
* **Expected but not present: ECG changes**: While not provided, one would expect to see ECG changes such as ST-segment elevation or Q-waves in the setting of an MI. The absence of these findings would oppose the diagnosis of MI.

**2. Unstable Angina**

* **Severe and constant chest pain**: The patient's chest pain is described as severe and constant, which is more typical of MI than unstable angina. Unstable angina typically presents with chest pain that is new, worsening, or occurring at rest.
* **Elevated troponin I**: The elevated troponin I level suggests myocardial damage, which is more consistent with MI than unstable angina.
* **Expected but not present: ECG changes**: One would expect to see ECG changes such as ST-segment depression or T-wave inversion in the setting of unstable angina. The absence of these findings would oppose the diagnosis of unstable angina.
* **No reported recent increase in angina frequency**: The patient does not report a recent increase in angina frequency or severity, which is a common feature of unstable angina.

**3. Acute Coronary Syndrome (ACS)**

* **Absence of shortness of breath**: The patient denies shortness of breath, which is a common symptom of ACS, particularly if there is associated heart failure or pulmonary edema.
* **Normal pulmonary examination**: The patient's lungs are clear to auscultation bilaterally, which makes pulmonary edema or cardiogenic shock less likely.
* **Expected but not present: ECG changes**: While not provided, one would expect to see ECG changes such as ST-segment elevation or depression, Q-waves, or T-wave inversion in the setting of ACS. The absence of these findings would oppose the diagnosis of ACS.
* **No reported recent increase in angina frequency**: The patient does not report a recent increase in angina frequency or severity, which is a common feature of ACS.

Note that these opposing findings do not necessarily rule out each diagnosis, but rather highlight the complexity of the patient's presentation and the need for further evaluation and testing to confirm the diagnosis.","Based on the patient's presentation, history, and laboratory results, the final diagnosis is:

**Acute Myocardial Infarction (MI)**

The diagnosis of MI is supported by the following key findings:

1. **Chest pain characteristics**: The patient's chest pain is described as crushing, severe, and constant, which is consistent with the typical presentation of an MI.
2. **Elevated troponin I**: The troponin I level of 3.2 ng/mL is elevated, which is a sensitive and specific marker for myocardial damage.
3. **History of risk factors**: The patient has a history of hypertension, hyperlipidemia, and smoking (30 pack-years), which are all significant risk factors for the development of coronary artery disease and MI.
4. **Family history**: The patient's family history of cardiovascular disease, with both parents having had MIs in their 50s, also increases his risk of developing an MI.

While the patient's presentation is consistent with MI, it is also possible that the patient has unstable angina or another form of acute coronary syndrome (ACS). However, the elevated troponin I level and the severity of the patient's chest pain make MI the most likely diagnosis.

**Management and Treatment**:

The patient should be managed and treated according to the current guidelines for acute MI, which include:

1. **Immediate activation of the cardiac catheterization laboratory**: The patient should be taken to the cardiac catheterization laboratory for urgent coronary angiography and possible percutaneous coronary intervention (PCI).
2. **Administration of aspirin and other antiplatelet agents**: The patient should be given aspirin and other antiplatelet agents, such as clopidogrel or ticagrelor, to reduce the risk of further thrombosis.
3. **Administration of anticoagulants**: The patient should be given anticoagulants, such as heparin or enoxaparin, to reduce the risk of further thrombosis.
4. **Administration of beta blockers and nitrates**: The patient should be given beta blockers and nitrates to reduce the workload on the heart and improve cardiac function.
5. **Monitoring and supportive care**: The patient should be closely monitored for signs of complications, such as arrhythmias, heart failure, or cardiogenic shock, and should receive supportive care, such as oxygen therapy and pain management, as needed.","Based on the patient's presentation and diagnosis of acute myocardial infarction (MI), the following additional steps should be taken:

1. **Electrocardiogram (ECG) interpretation**: An ECG should be performed immediately to assess for signs of ischemia or infarction, such as ST-segment elevation or Q-waves.
2. **Cardiac biomarker testing**: In addition to troponin I, other cardiac biomarkers such as creatine kinase (CK) and CK-MB should be measured to confirm the diagnosis of MI.
3. **Echocardiogram**: An echocardiogram should be performed to assess left ventricular function and to evaluate for any signs of wall motion abnormalities or other structural heart disease.
4. **Coronary angiography**: The patient should undergo coronary angiography to identify the culprit lesion and to assess for any other significant coronary artery disease.
5. **Percutaneous coronary intervention (PCI)**: If the coronary angiogram shows a significant lesion, PCI should be performed to restore blood flow to the affected area of the heart.
6. **Medical therapy**: The patient should be started on medical therapy, including:
	* Aspirin: 162-325 mg orally daily
	* Clopidogrel: 600 mg orally loading dose, followed by 75 mg orally daily
	* Beta blocker: e.g. metoprolol 25-50 mg orally daily
	* ACE inhibitor or ARB: e.g. lisinopril 10-20 mg orally daily
	* Statin: e.g. atorvastatin 80 mg orally daily
7. **Monitoring and supportive care**: The patient should be closely monitored for signs of complications, such as arrhythmias, heart failure, or cardiogenic shock, and should receive supportive care, such as oxygen therapy and pain management, as needed.
8. **Risk factor modification**: The patient should be counseled on risk factor modification, including:
	* Smoking cessation
	* Dietary changes: e.g. low-sodium, low-fat diet
	* Exercise: e.g. cardiac rehabilitation program
	* Weight management
	* Blood pressure control
	* Lipid management
9. **Follow-up appointments**: The patient should be scheduled for follow-up appointments with a cardiologist to monitor their progress and to adjust their treatment plan as needed.

**Additional considerations**:

* The patient's diabetes and hypertension should be managed according to current guidelines.
* The patient's hyperlipidemia should be managed with a statin and other lipid-lowering therapies as needed.
* The patient should be screened for other cardiovascular risk factors, such as family history of cardiovascular disease, and should be counseled on risk factor modification.
* The patient should be considered for cardiac rehabilitation program to improve their cardiovascular health and to reduce their risk of future cardiovascular events.","{""Score"":2,""Rationale"":""The answer includes Acute Myocardial Infarction (MI) and Unstable Angina, which match two items in the rubric. The third item listed, Acute Coronary Syndrome (ACS), does not match Gastroesophageal Reflux Disease (GERD) from the rubric, so no point is awarded for that.""}","{""Score"":4,""Rationale"":""The answer correctly includes the key features for Acute Myocardial Infarction and Unstable Angina as outlined in the rubric, earning 2 points each. However, it does not address Gastroesophageal Reflux Disease, which is required for the third set of points, and instead adds an unrelated diagnosis (ACS). Therefore, no points are awarded for the GERD component, resulting in a total of 4 out of 6 points.""}","{""Score"":0,""Rationale"":""Student's answer does not match any of the specific opposing findings listed in the rubric for MI, Unstable Angina, or GERD; they provide different or additional diagnoses and lack the exact concepts required for credit.""}","{""Score"":1,""Rationale"":""The answer correctly identifies Acute Myocardial Infarction and includes crushing chest pain, elevated troponin, and risk factors, matching several rubric concepts. However, it omits the ST-segment elevation mentioned in the rubric, so it does not fully meet the high‑scoring example.""}","{""Score"":2,""Rationale"":""The answer includes coronary angiography, matching one rubric item (2 points). It mentions aspirin but omits heparin, and does not mention nitroglycerin, so the other two items receive no points.""}",9.0
"History of Present Illness
A 60-year-old male with a recent history of hip replacement surgery 2 weeks ago presents with sudden onset of shortness of breath and pleuritic chest pain. The pain is sharp and worsens with deep breathing or coughing. He has been feeling progressively more breathless, even while at rest, and also reports a mild cough. He denies fever or hemoptysis but admits to feeling fatigued and dizzy on exertion. He has not been able to move around much post-surgery, and has been primarily confined to bed. He has no known history of deep vein thrombosis (DVT).

  Past Medical History
He has a history of osteoarthritis, for which he underwent the recent hip replacement. He has no known history of cardiovascular or respiratory disease. No significant family history of pulmonary embolism or clotting disorders. He is a non-smoker and does not drink alcohol.

  Physical Examination
VITALS: BP 130/85 mmHg, pulse 110 bpm, temperature 98.7°F, respiratory rate 22/min. GEN: Mildly anxious, appears in moderate distress due to breathing difficulties. CARDIAC: Tachycardic, regular rhythm, no murmurs. 
PULM: Tachypneic, decreased breath sounds at the right base, no wheezing. 
ABD: Soft, non-tender. 
MSK: Limited movement of the right hip due to recent surgery. 
EXT: Mild swelling in the right lower leg, no redness or warmth. 
SKIN: No rashes, warm extremities.

  Laboratory Results
D-dimer: 8.5 µg/mL (elevated). Chest CT angiogram: Acute pulmonary embolism in the right lower lobe pulmonary artery. ABG: pO2 70 mmHg, pCO2 35 mmHg.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Pulmonary Embolism (PE)**: The patient's symptoms of sudden onset shortness of breath, pleuritic chest pain, and elevated D-dimer, along with the chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery, strongly support this diagnosis.
2. **Deep Vein Thrombosis (DVT)**: The patient's recent history of hip replacement surgery, immobility, and mild swelling in the right lower leg suggest a possible DVT, which could be a source of the pulmonary embolism.
3. **Pneumonia**: Although the patient denies fever and hemoptysis, the symptoms of shortness of breath, pleuritic chest pain, and decreased breath sounds at the right base could also be consistent with pneumonia, particularly if the pulmonary embolism has caused infarction of the lung tissue. However, the chest CT angiogram and laboratory results make PE a more likely diagnosis.","Here are the findings and risk factors supporting each possible diagnosis:

**1. Pulmonary Embolism (PE)**

* Supporting findings:
	+ Sudden onset of shortness of breath and pleuritic chest pain
	+ Elevated D-dimer (8.5 µg/mL)
	+ Chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery
	+ Decreased breath sounds at the right base on physical examination
	+ Tachypnea (respiratory rate 22/min) and tachycardia (pulse 110 bpm)
* Risk factors:
	+ Recent hip replacement surgery, which increases the risk of venous thromboembolism (VTE)
	+ Immobility post-surgery, which increases the risk of VTE
	+ Age (60 years), which is a risk factor for VTE

**2. Deep Vein Thrombosis (DVT)**

* Supporting findings:
	+ Mild swelling in the right lower leg
	+ Recent hip replacement surgery, which increases the risk of VTE
	+ Immobility post-surgery, which increases the risk of VTE
* Risk factors:
	+ Recent hip replacement surgery, which increases the risk of VTE
	+ Immobility post-surgery, which increases the risk of VTE
	+ Age (60 years), which is a risk factor for VTE
	+ Limited movement of the right hip due to recent surgery, which may have contributed to venous stasis

**3. Pneumonia**

* Supporting findings:
	+ Shortness of breath and pleuritic chest pain
	+ Decreased breath sounds at the right base on physical examination
	+ Tachypnea (respiratory rate 22/min)
* Risk factors:
	+ Recent surgery, which may have increased the risk of aspiration or respiratory complications
	+ Age (60 years), which is a risk factor for pneumonia
	+ Immobility post-surgery, which may have increased the risk of respiratory complications
	+ However, the lack of fever, hemoptysis, and other typical symptoms of pneumonia, as well as the presence of a clear alternative diagnosis (PE), make this diagnosis less likely.","Here are the findings opposing each possible diagnosis, or findings that were expected but not present:

**1. Pulmonary Embolism (PE)**

* Opposing findings:
	+ The patient's oxygen saturation is not severely impaired (pO2 70 mmHg), which might be expected in a larger or more central PE.
	+ The patient does not have a history of DVT or known risk factors for thrombophilia, which might increase the suspicion for PE.
	+ The patient's blood pressure is relatively stable (BP 130/85 mmHg), which might not be expected in a large or hemodynamically significant PE.
* Expected findings that are not present:
	+ Hemoptysis, which can occur in up to 20% of patients with PE, but is not present in this patient.
	+ A more significant decrease in oxygen saturation, which might be expected in a larger or more central PE.
	+ Signs of right heart strain, such as an S1Q3T3 pattern on ECG or elevated troponin, which are not mentioned in the case.

**2. Deep Vein Thrombosis (DVT)**

* Opposing findings:
	+ The patient does not have significant swelling, redness, or warmth in the affected leg, which are common signs of DVT.
	+ The patient does not have a history of DVT or known risk factors for thrombophilia, which might increase the suspicion for DVT.
	+ The patient's symptoms are more consistent with a pulmonary issue (shortness of breath, pleuritic chest pain) than a lower extremity issue.
* Expected findings that are not present:
	+ Significant swelling, redness, or warmth in the affected leg, which are common signs of DVT.
	+ A positive Homan's sign (pain in the calf or behind the knee when the foot is dorsiflexed), which is a classic sign of DVT.
	+ A more significant elevation in D-dimer, which might be expected in a larger or more proximal DVT.

**3. Pneumonia**

* Opposing findings:
	+ The patient does not have a fever, which is a common symptom of pneumonia.
	+ The patient does not have a productive cough or hemoptysis, which are common symptoms of pneumonia.
	+ The chest CT angiogram shows a pulmonary embolism, which is not consistent with pneumonia.
* Expected findings that are not present:
	+ Fever, which is a common symptom of pneumonia.
	+ Productive cough or hemoptysis, which are common symptoms of pneumonia.
	+ Signs of consolidation on physical examination, such as dullness to percussion or bronchial breath sounds, which are not mentioned in the case.
	+ A more significant elevation in white blood cell count or other inflammatory markers, which might be expected in pneumonia.","Based on the patient's presentation, physical examination, laboratory results, and imaging studies, the final diagnosis is:

**Acute Pulmonary Embolism (PE)**

The diagnosis is supported by the following key findings:

* Sudden onset of shortness of breath and pleuritic chest pain
* Elevated D-dimer (8.5 µg/mL)
* Chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery
* Decreased breath sounds at the right base on physical examination
* Tachypnea (respiratory rate 22/min) and tachycardia (pulse 110 bpm)

The patient's recent hip replacement surgery and immobility post-surgery are significant risk factors for developing a pulmonary embolism. The presence of a pulmonary embolism is confirmed by the chest CT angiogram, which is a highly sensitive and specific test for diagnosing PE.

The patient's symptoms and laboratory results are consistent with a pulmonary embolism, and the diagnosis is further supported by the absence of alternative explanations for the patient's symptoms, such as pneumonia or other respiratory conditions.

**Treatment:**

The patient should be treated with anticoagulation therapy, such as low-molecular-weight heparin (LMWH) or unfractionated heparin, to prevent further clot formation and to reduce the risk of recurrent PE. The patient may also require oxygen therapy and other supportive care to manage symptoms and prevent complications.

**Further Management:**

The patient's treatment plan should include:

* Anticoagulation therapy for at least 3-6 months
* Monitoring for signs of recurrent PE or anticoagulant-related bleeding
* Evaluation for underlying thrombophilic conditions, such as factor V Leiden or antithrombin deficiency
* Consideration of inferior vena cava (IVC) filter placement if anticoagulation is contraindicated or if the patient has a high risk of recurrent PE.","Based on the final diagnosis of acute pulmonary embolism (PE), the following additional steps should be taken:

1. **Initiate anticoagulation therapy**: Start the patient on anticoagulation therapy with low-molecular-weight heparin (LMWH) or unfractionated heparin to prevent further clot formation and reduce the risk of recurrent PE.
2. **Monitor for signs of recurrent PE or anticoagulant-related bleeding**: Closely monitor the patient for signs of recurrent PE, such as worsening shortness of breath, chest pain, or hypoxia, and for signs of anticoagulant-related bleeding, such as bruising, petechiae, or hematuria.
3. **Order additional laboratory tests**: Order additional laboratory tests, such as:
	* Complete blood count (CBC) to monitor for thrombocytopenia or anemia
	* Prothrombin time (PT) and activated partial thromboplastin time (aPTT) to monitor anticoagulation therapy
	* D-dimer to monitor for recurrent PE
	* Troponin to evaluate for cardiac injury
4. **Perform a lower extremity Doppler ultrasound**: Perform a lower extremity Doppler ultrasound to evaluate for deep vein thrombosis (DVT) and to identify the source of the pulmonary embolism.
5. **Consult with a specialist**: Consult with a specialist, such as a cardiologist or a pulmonologist, to discuss the patient's management and treatment plan.
6. **Develop a plan for long-term anticoagulation**: Develop a plan for long-term anticoagulation, including the type and duration of anticoagulation therapy, and the need for regular monitoring and follow-up.
7. **Educate the patient and family**: Educate the patient and family on the diagnosis, treatment, and management of pulmonary embolism, including the importance of anticoagulation therapy and the need for regular follow-up.
8. **Consider thrombolytic therapy**: Consider thrombolytic therapy if the patient has a high-risk PE, such as a saddle embolus or a large peripheral embolus, and is hemodynamically unstable.
9. **Consider inferior vena cava (IVC) filter placement**: Consider IVC filter placement if the patient has a contraindication to anticoagulation therapy or has a high risk of recurrent PE.
10. **Document the patient's treatment plan and progress**: Document the patient's treatment plan and progress, including the results of laboratory tests and imaging studies, and the patient's response to treatment.","{""Score"":3,""Rationale"":""Student listed Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), and Pneumonia, matching all three concepts in the rubric.""}","{""Score"":6,""Rationale"":""The answer includes the required PE findings (recent hip surgery, immobility, elevated D‑dimer, sudden SOB, pleuritic pain, tachypnea, CT confirmation). It notes pneumonia’s typical signs and correctly emphasizes the lack of fever (making it less likely). It also lists DVT indicators (leg swelling, recent surgery) consistent with the rubric. All three diagnoses meet the rubric concepts, earning full marks.""}","{""Score"":4,""Rationale"":""The answer includes opposing findings for DVT (no redness/warmth, no prior history) and for Pneumonia (absence of fever), which match concepts in the rubric, earning 2 points each. However, for PE the rubric states there are no opposing findings, whereas the answer lists several opposing findings, so it does not match and receives no points. Total score is 4 out of 6.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Pulmonary Embolism, cites sudden shortness of breath, pleuritic chest pain, elevated D‑dimer, and CT angiogram confirmation, matching all concepts in the high‑scoring example.""}","{""Score"":4,""Rationale"":""The answer includes anticoagulation initiation and a lower extremity Doppler ultrasound (matching two rubric items), but does not mention oxygen therapy, thus earning 4 of 6 possible points.""}",19.0
"History of Present Illness
A 74-year-old female presents with a 1-month history of progressive fatigue, dizziness, and pale appearance. Over the last two weeks, she has noticed intermittent black, tarry stools and occasional bright red blood after bowel movements. She denies significant abdominal pain, nausea, or vomiting but mentions a history of occasional heartburn, which she manages with over-the-counter antacids. She has no history of hemorrhoids or significant gastrointestinal issues. She does not recall recent weight loss, but reports feeling more fatigued than usual.

  Past Medical History
She has a history of hypertension, controlled with an angiotensin II receptor blocker, and osteoarthritis. She is a former smoker (quit 10 years ago) and consumes alcohol occasionally. No family history of gastrointestinal cancers or bleeding disorders.

  Physical Examination
VITALS: BP 110/70 mmHg, pulse 88 bpm, temperature 98.2°F. 
GEN: Pale and fatigued-appearing. 
CARDIAC: Regular rhythm, no murmurs. 
PULM: Clear to auscultation bilaterally. 
ABD: Mild epigastric tenderness, no hepatosplenomegaly. No rebound tenderness or guarding. 
EXT: No edema, peripheral pulses intact. 
SKIN: Pale conjunctiva, no jaundice.

  Laboratory Results
Hemoglobin: 8.9 g/dL (low). Hematocrit: 27% (low). Platelets: 150 x 10^3/μL. Fecal occult blood test: Positive. Colonoscopy: Findings of multiple diverticula with no active bleeding. No masses or polyps observed.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Diverticular Disease with Chronic Bleeding**: The patient's colonoscopy showed multiple diverticula, which can cause chronic, intermittent bleeding leading to iron deficiency anemia, as evidenced by her low hemoglobin and hematocrit levels.
2. **Gastrointestinal Angiodysplasia**: This condition involves abnormal blood vessels in the gastrointestinal tract that can cause chronic bleeding, leading to anemia. The patient's age and lack of other gastrointestinal symptoms make this a possible diagnosis.
3. **Upper Gastrointestinal Bleeding (likely from a gastric or duodenal ulcer)**: The patient's history of occasional heartburn and use of antacids, combined with her symptoms of black, tarry stools (melena) and bright red blood after bowel movements, suggest the possibility of an upper GI bleed, potentially from a gastric or duodenal ulcer.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Diverticular Disease with Chronic Bleeding**

* Supportive findings:
	+ Colonoscopy showing multiple diverticula
	+ Positive fecal occult blood test (FOBT)
	+ Low hemoglobin and hematocrit levels, indicating anemia
	+ Patient's age (74 years), as diverticular disease is more common in older adults
* Risk factors:
	+ Age: Diverticular disease is more common in people over 60 years
	+ Lack of fiber in the diet: Although not explicitly mentioned, a low-fiber diet can contribute to the development of diverticula

**2. Gastrointestinal Angiodysplasia**

* Supportive findings:
	+ Patient's age (74 years), as angiodysplasia is more common in older adults
	+ Anemia (low hemoglobin and hematocrit levels)
	+ Positive FOBT
	+ Absence of other obvious sources of bleeding (e.g., no masses or polyps on colonoscopy)
* Risk factors:
	+ Age: Angiodysplasia is more common in people over 60 years
	+ Atherosclerotic disease: The patient has a history of hypertension, which may be a marker for atherosclerotic disease
	+ Chronic kidney disease: Although not mentioned, chronic kidney disease is a risk factor for angiodysplasia

**3. Upper Gastrointestinal Bleeding (likely from a gastric or duodenal ulcer)**

* Supportive findings:
	+ Black, tarry stools (melena), which suggest upper GI bleeding
	+ Bright red blood after bowel movements, which can occur if the bleeding is rapid
	+ History of occasional heartburn, which may indicate gastroesophageal reflux disease (GERD) or peptic ulcer disease
	+ Anemia (low hemoglobin and hematocrit levels)
* Risk factors:
	+ Age: The patient is 74 years old, and the risk of peptic ulcer disease increases with age
	+ History of smoking: The patient is a former smoker, which increases the risk of peptic ulcer disease
	+ Use of antacids: Although the patient uses antacids to manage heartburn, this may not be sufficient to prevent ulcer formation or bleeding.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Diverticular Disease with Chronic Bleeding**

* Opposing findings:
	+ Absence of significant abdominal pain or tenderness, which is often present in patients with diverticulitis or diverticular bleeding
	+ No recent changes in bowel habits or stool caliber, which can occur with diverticular disease
	+ No evidence of significant inflammation or bleeding on colonoscopy, despite the presence of multiple diverticula
* Expected but not present findings:
	+ More significant abdominal tenderness or guarding, which is often present in patients with diverticular disease
	+ Evidence of diverticulitis or inflammation on colonoscopy or imaging studies

**2. Gastrointestinal Angiodysplasia**

* Opposing findings:
	+ The patient's anemia is relatively severe (Hb 8.9 g/dL), which is not typical for angiodysplasia, where the bleeding is often slower and more chronic
	+ The presence of black, tarry stools (melena) and bright red blood after bowel movements, which suggests a more active or rapid bleeding source than is typically seen with angiodysplasia
	+ The patient's colonoscopy did not show any evidence of angiodysplasia, although this does not entirely rule out the diagnosis
* Expected but not present findings:
	+ More subtle or gradual onset of anemia, as angiodysplasia often causes slow, chronic bleeding
	+ Evidence of angiodysplasia on colonoscopy, such as flat, vascular lesions or areas of mucosal bleeding

**3. Upper Gastrointestinal Bleeding (likely from a gastric or duodenal ulcer)**

* Opposing findings:
	+ The patient's colonoscopy showed no evidence of a bleeding source in the lower GI tract, but also did not evaluate the upper GI tract
	+ The patient's abdominal exam showed only mild epigastric tenderness, which is not typical for a significant upper GI bleed
	+ The patient's vital signs are relatively stable (BP 110/70 mmHg, pulse 88 bpm), which may not be expected in the setting of a significant upper GI bleed
* Expected but not present findings:
	+ More significant abdominal tenderness or guarding, particularly in the epigastric region
	+ Evidence of hematemesis (vomiting blood) or coffee ground emesis, which can occur with upper GI bleeding
	+ A more significant drop in hemoglobin or hematocrit over a shorter period, which can occur with rapid upper GI bleeding","Based on the patient's presentation, laboratory results, and colonoscopy findings, the final diagnosis is:

**Diverticular Disease with Chronic Bleeding**

Although the colonoscopy did not show active bleeding, the presence of multiple diverticula and the patient's symptoms of anemia, fatigue, and intermittent black, tarry stools (melena) and bright red blood after bowel movements are consistent with chronic bleeding from diverticula. The patient's age, lack of other obvious sources of bleeding, and the positive fecal occult blood test (FOBT) also support this diagnosis.

The patient's anemia is likely due to chronic blood loss from the diverticula, which can be slow and intermittent. The fact that the patient's hemoglobin and hematocrit levels are low, but not critically low, suggests that the bleeding is chronic rather than acute.

While upper GI bleeding (e.g., from a gastric or duodenal ulcer) is a possible diagnosis, the patient's symptoms and laboratory results do not strongly support this diagnosis. The patient's colonoscopy did not evaluate the upper GI tract, but the presence of black, tarry stools (melena) and bright red blood after bowel movements could be consistent with either upper or lower GI bleeding.

Gastrointestinal angiodysplasia is also a possible diagnosis, but the patient's age and lack of other risk factors (e.g., chronic kidney disease, atherosclerotic disease) make this diagnosis less likely.

Overall, the patient's presentation and laboratory results are most consistent with diverticular disease with chronic bleeding, and further evaluation and management should focus on this diagnosis.","Based on the final diagnosis of Diverticular Disease with Chronic Bleeding, the following additional steps can be taken:

1. **Upper Endoscopy**: To rule out an upper GI source of bleeding, an upper endoscopy can be performed to evaluate the esophagus, stomach, and duodenum for any potential bleeding sources, such as ulcers or angiodysplasia.
2. **Iron Supplementation**: To manage the patient's anemia, iron supplementation can be started to replenish iron stores and improve hemoglobin levels.
3. **Colonoscopy with Tattooing**: If the patient's bleeding is thought to be coming from a specific diverticulum, a colonoscopy with tattooing can be performed to mark the location of the bleeding diverticulum for potential future intervention.
4. **Diverticular Bleeding Management**: The patient can be managed conservatively with iron supplementation and monitoring of their hemoglobin levels. If the bleeding persists or worsens, other options such as endoscopic clipping or banding, or even surgical intervention, may be considered.
5. **Risk Factor Modification**: The patient's risk factors for diverticular disease, such as low fiber intake and lack of physical activity, can be addressed through dietary counseling and encouragement of regular exercise.
6. **Follow-up**: The patient should be followed up regularly to monitor their hemoglobin levels, assess for any changes in symptoms, and adjust their management plan as needed.
7. **Consideration of Angiographic Embolization**: If the patient's bleeding is severe or recurrent, angiographic embolization can be considered to control the bleeding.
8. **Surgical Evaluation**: If the patient's bleeding is severe or recurrent and cannot be controlled with endoscopic or angiographic interventions, surgical evaluation may be necessary to consider options such as diverticulectomy or segmental resection.

In terms of specific tests, the following can be ordered:

* **Complete Blood Count (CBC)**: To monitor the patient's hemoglobin levels and assess for any changes in their anemia.
* **Iron Studies**: To assess the patient's iron stores and guide iron supplementation.
* **Stool Studies**: To assess for any changes in the patient's stool and monitor for any signs of bleeding.
* **Imaging Studies**: Such as a CT scan or MRI, to evaluate the patient's diverticula and assess for any other potential sources of bleeding.

In terms of specific medications, the following can be considered:

* **Iron Supplements**: To replenish the patient's iron stores and improve their hemoglobin levels.
* **Proton Pump Inhibitors (PPIs)**: To reduce acid production in the stomach and help manage any upper GI symptoms.
* **Anti-diarrheal Medications**: To manage any diarrhea or bowel irregularity associated with diverticular disease.","{""Score"":1,""Rationale"":""Only the third diagnosis (Upper GI Bleeding likely from a gastric or duodenal ulcer) matches a concept in the high‑scoring example (Peptic Ulcer Disease with Upper GI Bleeding). The other two diagnoses (Diverticular Disease and Angiodysplasia) are not listed in the rubric, so no points are awarded for them.""}","{""Score"":2,""Rationale"":""The answer includes a diagnosis matching Peptic Ulcer Disease (melena, heartburn, antacid use, anemia, positive FOBT) earning 2 points, but does not address the other two rubric diagnoses (Gastritis with chronic GI bleeding and Gastrointestinal malignancy), so no points for those.""}","{""Score"":0,""Rationale"":""The answer does not mention any of the rubric concepts (NSAID use for PUD, lack of endoscopic confirmation for gastritis, or findings related to gastrointestinal malignancy); therefore no points are awarded.""}","{""Score"":1,""Rationale"":""The answer includes melena, anemia, a positive fecal occult blood test, and notes the absence of active lower GI bleeding on colonoscopy, matching part of the rubric. However, it omits the required concept of a history of heartburn and proposes a different diagnosis, so it does not fully meet the rubric criteria for the full 2 points.""}","{""Score"":4,""Rationale"":""The answer includes Upper Endoscopy and PPI therapy, matching two rubric items (2 points each). It mentions monitoring hemoglobin but does not address blood transfusion, and it omits Helicobacter pylori assessment, so those items receive no points.""}",8.0
,,,,,,,,,,,,,,,,
